HRP20200837T1 - Derivati 3-((hetero-)aril)-alkil-8-amino-2-okso-1,3-diaza-spiro-[4.5]-dekana - Google Patents
Derivati 3-((hetero-)aril)-alkil-8-amino-2-okso-1,3-diaza-spiro-[4.5]-dekana Download PDFInfo
- Publication number
- HRP20200837T1 HRP20200837T1 HRP20200837TT HRP20200837T HRP20200837T1 HR P20200837 T1 HRP20200837 T1 HR P20200837T1 HR P20200837T T HRP20200837T T HR P20200837TT HR P20200837 T HRP20200837 T HR P20200837T HR P20200837 T1 HRP20200837 T1 HR P20200837T1
- Authority
- HR
- Croatia
- Prior art keywords
- methyl
- phenyl
- diazaspiro
- cis
- decan
- Prior art date
Links
- 125000003118 aryl group Chemical group 0.000 title 1
- 229920006395 saturated elastomer Polymers 0.000 claims 44
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims 29
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 23
- 125000004093 cyano group Chemical group *C#N 0.000 claims 22
- 125000001424 substituent group Chemical group 0.000 claims 18
- -1 2 -cyclobutyl- Chemical group 0.000 claims 15
- 150000001875 compounds Chemical class 0.000 claims 15
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 15
- 125000006708 (C5-C14) heteroaryl group Chemical group 0.000 claims 14
- 125000005915 C6-C14 aryl group Chemical group 0.000 claims 14
- 125000006652 (C3-C12) cycloalkyl group Chemical group 0.000 claims 11
- 125000006707 (C3-C12) heterocycloalkyl group Chemical group 0.000 claims 11
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 9
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Substances N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 claims 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 7
- 150000003839 salts Chemical class 0.000 claims 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 4
- 229910052757 nitrogen Inorganic materials 0.000 claims 4
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Substances CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 3
- QUVDCWLEMFTCQX-UHFFFAOYSA-N 8-(dimethylamino)-1-ethyl-3-[(4-methoxyphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound CCN1C(=O)N(Cc2ccc(OC)cc2)CC11CCC(CC1)(N(C)C)c1ccccc1 QUVDCWLEMFTCQX-UHFFFAOYSA-N 0.000 claims 2
- ACPQZFFQLKGWON-UHFFFAOYSA-N 8-(dimethylamino)-3-[(4-methoxyphenyl)methyl]-1-(oxolan-3-ylmethyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3ccccc3)N(CC3CCOC3)C2=O)cc1 ACPQZFFQLKGWON-UHFFFAOYSA-N 0.000 claims 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 1
- SGGMATVTIPUWKX-UHFFFAOYSA-N 1-(2-cyclobutylethyl)-8-(dimethylamino)-3-[(4-methoxyphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3ccccc3)N(CCC3CCC3)C2=O)cc1 SGGMATVTIPUWKX-UHFFFAOYSA-N 0.000 claims 1
- BCBRYUWDAGLKPS-UHFFFAOYSA-N 1-(2-cyclohexylethyl)-8-(dimethylamino)-3-[(4-methoxyphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3ccccc3)N(CCC3CCCCC3)C2=O)cc1 BCBRYUWDAGLKPS-UHFFFAOYSA-N 0.000 claims 1
- QNBCHHJSUDHSIL-UHFFFAOYSA-N 1-(cyclobutylmethyl)-3-[(3-methoxyphenyl)methyl]-8-(methylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound C1(CCC1)CN1C(N(CC11CCC(CC1)(C1=CC=CC=C1)NC)CC1=CC(=CC=C1)OC)=O QNBCHHJSUDHSIL-UHFFFAOYSA-N 0.000 claims 1
- PEWXZFSEKJFKOF-UHFFFAOYSA-N 1-(cyclobutylmethyl)-3-[(3-methoxyphenyl)methyl]-8-[methyl(propyl)amino]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound C1(CCC1)CN1C(N(CC11CCC(CC1)(C1=CC=CC=C1)N(CCC)C)CC1=CC(=CC=C1)OC)=O PEWXZFSEKJFKOF-UHFFFAOYSA-N 0.000 claims 1
- HDACKSUZWAPUAP-UHFFFAOYSA-N 1-(cyclobutylmethyl)-3-[(4-methoxyphenyl)methyl]-8-(methylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound C1(CCC1)CN1C(N(CC11CCC(CC1)(C1=CC=CC=C1)NC)CC1=CC=C(C=C1)OC)=O HDACKSUZWAPUAP-UHFFFAOYSA-N 0.000 claims 1
- QJAIUODYPSAJPR-UHFFFAOYSA-N 1-(cyclobutylmethyl)-3-[(4-methoxyphenyl)methyl]-8-[methyl(prop-2-enyl)amino]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)CC=C)c3ccccc3)N(CC3CCC3)C2=O)cc1 QJAIUODYPSAJPR-UHFFFAOYSA-N 0.000 claims 1
- RQOVYXMPEPGWDI-UHFFFAOYSA-N 1-(cyclobutylmethyl)-3-[[1-(2-hydroxyethyl)triazol-4-yl]methyl]-8-(methylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound CNC1(CCC2(CN(CC3=CN(CCO)N=N3)C(=O)N2CC2CCC2)CC1)C1=CC=CC=C1 RQOVYXMPEPGWDI-UHFFFAOYSA-N 0.000 claims 1
- GMXJRLCDFKLCGY-UHFFFAOYSA-N 1-(cyclobutylmethyl)-8-(dimethylamino)-3-[(3-methoxyphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound C1(CCC1)CN1C(N(CC11CCC(CC1)(C1=CC=CC=C1)N(C)C)CC1=CC(=CC=C1)OC)=O GMXJRLCDFKLCGY-UHFFFAOYSA-N 0.000 claims 1
- PEPORJMKLNYBKB-UHFFFAOYSA-N 1-(cyclobutylmethyl)-8-(dimethylamino)-3-[(3-methylsulfonylphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C)C1(CCC2(CN(Cc3cccc(c3)S(C)(=O)=O)C(=O)N2CC2CCC2)CC1)c1ccccc1 PEPORJMKLNYBKB-UHFFFAOYSA-N 0.000 claims 1
- PNGFHKYHCNALQP-UHFFFAOYSA-N 1-(cyclobutylmethyl)-8-(dimethylamino)-3-[(4-hydroxyphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C)C1(CCC2(CN(Cc3ccc(O)cc3)C(=O)N2CC2CCC2)CC1)c1ccccc1 PNGFHKYHCNALQP-UHFFFAOYSA-N 0.000 claims 1
- RAODKODTBAFUCM-UHFFFAOYSA-N 1-(cyclobutylmethyl)-8-(dimethylamino)-3-[(4-methoxyphenyl)methyl]-8-(3-methoxypropyl)-1,3-diazaspiro[4.5]decan-2-one Chemical compound COCCCC1(CCC2(CN(Cc3ccc(OC)cc3)C(=O)N2CC2CCC2)CC1)N(C)C RAODKODTBAFUCM-UHFFFAOYSA-N 0.000 claims 1
- LTWIXTDRAFZAPF-UHFFFAOYSA-N 1-(cyclobutylmethyl)-8-(dimethylamino)-3-[(4-methoxyphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3ccccc3)N(CC3CCC3)C2=O)cc1 LTWIXTDRAFZAPF-UHFFFAOYSA-N 0.000 claims 1
- BARLHUVNIVYXMO-UHFFFAOYSA-N 1-(cyclobutylmethyl)-8-(dimethylamino)-3-[(4-methylsulfonylphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C)C1(CCC2(CN(Cc3ccc(cc3)S(C)(=O)=O)C(=O)N2CC2CCC2)CC1)c1ccccc1 BARLHUVNIVYXMO-UHFFFAOYSA-N 0.000 claims 1
- VBLSOCKFYRCTFP-UHFFFAOYSA-N 1-(cyclobutylmethyl)-8-(dimethylamino)-3-[[1-(2-hydroxyethyl)triazol-4-yl]methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C)C1(CCC2(CN(Cc3cn(CCO)nn3)C(=O)N2CC2CCC2)CC1)c1ccccc1 VBLSOCKFYRCTFP-UHFFFAOYSA-N 0.000 claims 1
- GECAMOXGPHHIKU-UHFFFAOYSA-N 1-(cyclobutylmethyl)-8-(dimethylamino)-3-[[3-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]phenyl]methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound COCCOCCOCCOCCOCCOCCOc1cccc(CN2CC3(CCC(CC3)(N(C)C)c3ccccc3)N(CC3CCC3)C2=O)c1 GECAMOXGPHHIKU-UHFFFAOYSA-N 0.000 claims 1
- GFTBNQDZJMFSDP-UHFFFAOYSA-N 1-(cyclobutylmethyl)-8-(dimethylamino)-3-[[4-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]phenyl]methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound COCCOCCOCCOCCOCCOCCOCCOCCOc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3ccccc3)N(CC3CCC3)C2=O)cc1 GFTBNQDZJMFSDP-UHFFFAOYSA-N 0.000 claims 1
- WRLWEGOEFBBBJN-UHFFFAOYSA-N 1-(cyclobutylmethyl)-8-(dimethylamino)-8-(3-fluorophenyl)-3-[(4-methoxyphenyl)methyl]-1,3-diazaspiro[4.5]decan-2-one Chemical compound C1(CCC1)CN1C(N(CC11CCC(CC1)(C1=CC(=CC=C1)F)N(C)C)CC1=CC=C(C=C1)OC)=O WRLWEGOEFBBBJN-UHFFFAOYSA-N 0.000 claims 1
- VXOYQGDCUZXHBD-UHFFFAOYSA-N 1-(cyclobutylmethyl)-8-(dimethylamino)-8-(3-hydroxyphenyl)-3-[(4-methoxyphenyl)methyl]-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3cccc(O)c3)N(CC3CCC3)C2=O)cc1 VXOYQGDCUZXHBD-UHFFFAOYSA-N 0.000 claims 1
- DJFZBCVQEHKNNP-UHFFFAOYSA-N 1-(cyclobutylmethyl)-8-(dimethylamino)-8-(3-methoxyphenyl)-3-[(4-methoxyphenyl)methyl]-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3cccc(OC)c3)N(CC3CCC3)C2=O)cc1 DJFZBCVQEHKNNP-UHFFFAOYSA-N 0.000 claims 1
- ZJSRAQNSQCIMIR-UHFFFAOYSA-N 1-(cyclobutylmethyl)-8-(dimethylamino)-8-(4-fluorophenyl)-3-[(4-methoxyphenyl)methyl]-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3ccc(F)cc3)N(CC3CCC3)C2=O)cc1 ZJSRAQNSQCIMIR-UHFFFAOYSA-N 0.000 claims 1
- YSJKGOYGPSKNGB-UHFFFAOYSA-N 1-(cyclobutylmethyl)-8-(dimethylamino)-8-(4-hydroxyphenyl)-3-[(4-methoxyphenyl)methyl]-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3ccc(O)cc3)N(CC3CCC3)C2=O)cc1 YSJKGOYGPSKNGB-UHFFFAOYSA-N 0.000 claims 1
- IKOPGFJXCMHTLG-UHFFFAOYSA-N 1-(cyclobutylmethyl)-8-(dimethylamino)-8-(4-methoxyphenyl)-3-[(4-methoxyphenyl)methyl]-1,3-diazaspiro[4.5]decan-2-one Chemical compound C1(CCC1)CN1C(N(CC11CCC(CC1)(C1=CC=C(C=C1)OC)N(C)C)CC1=CC=C(C=C1)OC)=O IKOPGFJXCMHTLG-UHFFFAOYSA-N 0.000 claims 1
- FHIDRVZPWLEQEB-UHFFFAOYSA-N 1-(cyclobutylmethyl)-8-(dimethylamino)-8-phenyl-3-(pyrazin-2-ylmethyl)-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C)C1(CCC2(CN(Cc3cnccn3)C(=O)N2CC2CCC2)CC1)c1ccccc1 FHIDRVZPWLEQEB-UHFFFAOYSA-N 0.000 claims 1
- QNLCVVGGUNWQAS-UHFFFAOYSA-N 1-(cyclobutylmethyl)-8-(dimethylamino)-8-phenyl-3-(pyridin-2-ylmethyl)-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C)C1(CCC2(CN(Cc3ccccn3)C(=O)N2CC2CCC2)CC1)c1ccccc1 QNLCVVGGUNWQAS-UHFFFAOYSA-N 0.000 claims 1
- QFCYVANZZZLEKU-UHFFFAOYSA-N 1-(cyclobutylmethyl)-8-(dimethylamino)-8-phenyl-3-(pyridin-3-ylmethyl)-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C)C1(CCC2(CN(Cc3cccnc3)C(=O)N2CC2CCC2)CC1)c1ccccc1 QFCYVANZZZLEKU-UHFFFAOYSA-N 0.000 claims 1
- CAERYDTVNNPWIA-UHFFFAOYSA-N 1-(cyclobutylmethyl)-8-(dimethylamino)-8-phenyl-3-(pyridin-4-ylmethyl)-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C)C1(CCC2(CN(Cc3ccncc3)C(=O)N2CC2CCC2)CC1)c1ccccc1 CAERYDTVNNPWIA-UHFFFAOYSA-N 0.000 claims 1
- PASRXRDOVAGJNP-UHFFFAOYSA-N 1-(cyclobutylmethyl)-8-(methylamino)-8-phenyl-3-(pyridin-3-ylmethyl)-1,3-diazaspiro[4.5]decan-2-one Chemical compound CNC1(CCC2(CN(Cc3cccnc3)C(=O)N2CC2CCC2)CC1)c1ccccc1 PASRXRDOVAGJNP-UHFFFAOYSA-N 0.000 claims 1
- UYGFTRRNEDTVAD-UHFFFAOYSA-N 1-(cyclobutylmethyl)-8-[2-hydroxyethyl(methyl)amino]-3-[(4-methoxyphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)CCO)c3ccccc3)N(CC3CCC3)C2=O)cc1 UYGFTRRNEDTVAD-UHFFFAOYSA-N 0.000 claims 1
- ODGKMJBDZAKEOJ-UHFFFAOYSA-N 1-(cyclobutylmethyl)-8-[2-methoxyethyl(methyl)amino]-3-[(4-methoxyphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound COCCN(C)C1(CCC2(CN(Cc3ccc(OC)cc3)C(=O)N2CC2CCC2)CC1)c1ccccc1 ODGKMJBDZAKEOJ-UHFFFAOYSA-N 0.000 claims 1
- LOYKRVWFMCWRDF-UHFFFAOYSA-N 1-(cyclobutylmethyl)-8-[ethyl(methyl)amino]-3-[(3-methoxyphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound CCN(C)C1(CCC2(CN(Cc3cccc(OC)c3)C(=O)N2CC2CCC2)CC1)c1ccccc1 LOYKRVWFMCWRDF-UHFFFAOYSA-N 0.000 claims 1
- NVWJPWMESOJBIQ-UHFFFAOYSA-N 1-(cyclobutylmethyl)-8-[ethyl(methyl)amino]-3-[(4-methoxyphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound CCN(C)C1(CCC2(CN(Cc3ccc(OC)cc3)C(=O)N2CC2CCC2)CC1)c1ccccc1 NVWJPWMESOJBIQ-UHFFFAOYSA-N 0.000 claims 1
- KXCZYFLCZTWVIL-UHFFFAOYSA-N 1-(cyclobutylmethyl)-8-[ethyl(methyl)amino]-8-phenyl-3-(pyridin-3-ylmethyl)-1,3-diazaspiro[4.5]decan-2-one Chemical compound C1(CCC1)CN1C(N(CC11CCC(CC1)(C1=CC=CC=C1)N(C)CC)CC=1C=NC=CC=1)=O KXCZYFLCZTWVIL-UHFFFAOYSA-N 0.000 claims 1
- XGTYIJYODNDKSI-UHFFFAOYSA-N 1-(cyclohexylmethyl)-8-(dimethylamino)-3-[(4-methoxyphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3ccccc3)N(CC3CCCCC3)C2=O)cc1 XGTYIJYODNDKSI-UHFFFAOYSA-N 0.000 claims 1
- WUNJQJNBJJFXPQ-UHFFFAOYSA-N 1-(cyclopentylmethyl)-8-(dimethylamino)-3-[(4-methoxyphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3ccccc3)N(CC3CCCC3)C2=O)cc1 WUNJQJNBJJFXPQ-UHFFFAOYSA-N 0.000 claims 1
- LBRBAUKQYWJZGV-UHFFFAOYSA-N 1-(cyclopropylmethyl)-8-(dimethylamino)-3-[(4-methoxyphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound C1(CC1)CN1C(N(CC11CCC(CC1)(C1=CC=CC=C1)N(C)C)CC1=CC=C(C=C1)OC)=O LBRBAUKQYWJZGV-UHFFFAOYSA-N 0.000 claims 1
- RABKZFCSZJSVIG-UHFFFAOYSA-N 1-[(1-hydroxycyclobutyl)methyl]-3-[(4-methoxyphenyl)methyl]-8-(methylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound CNC1(CCC2(CN(Cc3ccc(OC)cc3)C(=O)N2CC2(O)CCC2)CC1)c1ccccc1 RABKZFCSZJSVIG-UHFFFAOYSA-N 0.000 claims 1
- UAUMNBLPPCLQJI-UHFFFAOYSA-N 1-[(1-hydroxycyclobutyl)methyl]-3-[[1-(2-hydroxyethyl)triazol-4-yl]methyl]-8-(methylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound CNC1(CCC2(CN(Cc3cn(CCO)nn3)C(=O)N2CC2(O)CCC2)CC1)c1ccccc1 UAUMNBLPPCLQJI-UHFFFAOYSA-N 0.000 claims 1
- MPXOSRRFFZVJAB-UHFFFAOYSA-N 1-benzyl-8-(dimethylamino)-3-[(4-methoxyphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3ccccc3)N(Cc3ccccc3)C2=O)cc1 MPXOSRRFFZVJAB-UHFFFAOYSA-N 0.000 claims 1
- AXVAABMMWSPIFS-UHFFFAOYSA-N 1-butyl-8-(dimethylamino)-3-[(4-methoxyphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound CCCCN1C(=O)N(Cc2ccc(OC)cc2)CC11CCC(CC1)(N(C)C)c1ccccc1 AXVAABMMWSPIFS-UHFFFAOYSA-N 0.000 claims 1
- IKOYSWCQXDHCDO-UHFFFAOYSA-N 2-[4-[[1-(cyclobutylmethyl)-8-(dimethylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]methyl]triazol-1-yl]acetamide Chemical compound CN(C)C1(CCC2(CN(Cc3cn(CC(N)=O)nn3)C(=O)N2CC2CCC2)CC1)c1ccccc1 IKOYSWCQXDHCDO-UHFFFAOYSA-N 0.000 claims 1
- YLNLBILMQYDBCG-UHFFFAOYSA-N 2-[4-[[1-(cyclobutylmethyl)-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]methyl]triazol-1-yl]acetamide Chemical compound CNC1(CCC2(CN(Cc3cn(CC(N)=O)nn3)C(=O)N2CC2CCC2)CC1)c1ccccc1 YLNLBILMQYDBCG-UHFFFAOYSA-N 0.000 claims 1
- YPVHFSTZSVAUNV-UHFFFAOYSA-N 2-[4-[[1-[(1-hydroxycyclobutyl)methyl]-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]methyl]triazol-1-yl]acetamide Chemical compound CNC1(CCC2(CN(Cc3cn(CC(N)=O)nn3)C(=O)N2CC2(O)CCC2)CC1)c1ccccc1 YPVHFSTZSVAUNV-UHFFFAOYSA-N 0.000 claims 1
- FFZAIIYNXSFMCO-UHFFFAOYSA-N 2-[4-[[8-(dimethylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]methyl]triazol-1-yl]acetamide Chemical compound CN(C)C1(CCC2(CN(CC3=CN(CC(N)=O)N=N3)C(=O)N2)CC1)C1=CC=CC=C1 FFZAIIYNXSFMCO-UHFFFAOYSA-N 0.000 claims 1
- ZXRRGVGLHHARAT-UHFFFAOYSA-N 2-[8-(dimethylamino)-3-[(4-methoxyphenyl)methyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-1-yl]-N,N-dimethylacetamide Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3ccccc3)N(CC(=O)N(C)C)C2=O)cc1 ZXRRGVGLHHARAT-UHFFFAOYSA-N 0.000 claims 1
- FDCCYBJKYXVZMA-UHFFFAOYSA-N 2-[8-(dimethylamino)-3-[(4-methoxyphenyl)methyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-1-yl]-N-methylacetamide Chemical compound CNC(=O)CN1C(=O)N(Cc2ccc(OC)cc2)CC11CCC(CC1)(N(C)C)c1ccccc1 FDCCYBJKYXVZMA-UHFFFAOYSA-N 0.000 claims 1
- QLCCLFSQGSEYDK-UHFFFAOYSA-N 2-[8-(dimethylamino)-3-[(4-methoxyphenyl)methyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-1-yl]-N-propylacetamide Chemical compound CCCNC(=O)CN1C(=O)N(Cc2ccc(OC)cc2)CC11CCC(CC1)(N(C)C)c1ccccc1 QLCCLFSQGSEYDK-UHFFFAOYSA-N 0.000 claims 1
- MZYWTWUHEDBUPO-UHFFFAOYSA-N 2-[8-(dimethylamino)-3-[(4-methoxyphenyl)methyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-1-yl]acetic acid Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3ccccc3)N(CC(O)=O)C2=O)cc1 MZYWTWUHEDBUPO-UHFFFAOYSA-N 0.000 claims 1
- NQNSOTSTQRWEFA-UHFFFAOYSA-N 2-[[1-(cyclobutylmethyl)-3-[(4-methoxyphenyl)methyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-8-yl]-methylamino]acetonitrile Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)CC#N)c3ccccc3)N(CC3CCC3)C2=O)cc1 NQNSOTSTQRWEFA-UHFFFAOYSA-N 0.000 claims 1
- KLRNHYAAJDBCDZ-UHFFFAOYSA-N 2-[[1-(cyclobutylmethyl)-8-(dimethylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]methyl]benzamide Chemical compound CN(C)C1(CCC2(CN(Cc3ccccc3C(N)=O)C(=O)N2CC2CCC2)CC1)c1ccccc1 KLRNHYAAJDBCDZ-UHFFFAOYSA-N 0.000 claims 1
- COXCTWQMLFTBNV-UHFFFAOYSA-N 2-[[1-(cyclobutylmethyl)-8-(dimethylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]methyl]benzonitrile Chemical compound CN(C)C1(CCC2(CN(Cc3ccccc3C#N)C(=O)N2CC2CCC2)CC1)c1ccccc1 COXCTWQMLFTBNV-UHFFFAOYSA-N 0.000 claims 1
- XXZDHFVKLHNUMC-UHFFFAOYSA-N 2-[[8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]methyl]benzamide Chemical compound CN(C)C1(CCC2(CN(Cc3ccccc3C(N)=O)C(=O)N2CC2(O)CCC2)CC1)c1ccccc1 XXZDHFVKLHNUMC-UHFFFAOYSA-N 0.000 claims 1
- GHBSGBINSHEWLA-UHFFFAOYSA-N 3-(1,3-benzodioxol-4-ylmethyl)-8-(dimethylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C)C1(CCC2(CN(Cc3cccc4OCOc34)C(=O)N2)CC1)c1ccccc1 GHBSGBINSHEWLA-UHFFFAOYSA-N 0.000 claims 1
- HESMNLHZPOJZMQ-UHFFFAOYSA-N 3-[(2-bromophenyl)methyl]-1-(cyclobutylmethyl)-8-(dimethylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C)C1(CCC2(CN(Cc3ccccc3Br)C(=O)N2CC2CCC2)CC1)c1ccccc1 HESMNLHZPOJZMQ-UHFFFAOYSA-N 0.000 claims 1
- PROZJMQQFSDKGS-UHFFFAOYSA-N 3-[(3-cyclopropylphenyl)methyl]-8-(dimethylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C)C1(CCC2(CN(Cc3cccc(c3)C3CC3)C(=O)N2)CC1)c1ccccc1 PROZJMQQFSDKGS-UHFFFAOYSA-N 0.000 claims 1
- BAVUHYFEHNCBQJ-UHFFFAOYSA-N 3-[8-(dimethylamino)-3-[(4-methoxyphenyl)methyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-1-yl]-2,2-dimethylpropanenitrile Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3ccccc3)N(CC(C)(C)C#N)C2=O)cc1 BAVUHYFEHNCBQJ-UHFFFAOYSA-N 0.000 claims 1
- KGCKWOLCQQVPIU-UHFFFAOYSA-N 3-[[1-(cyclobutylmethyl)-8-(dimethylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]methyl]benzamide Chemical compound CN(C)C1(CCC2(CN(Cc3cccc(c3)C(N)=O)C(=O)N2CC2CCC2)CC1)c1ccccc1 KGCKWOLCQQVPIU-UHFFFAOYSA-N 0.000 claims 1
- FULKUJGTRBNCGE-UHFFFAOYSA-N 3-[[1-(cyclobutylmethyl)-8-(dimethylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]methyl]benzonitrile Chemical compound CN(C)C1(CCC2(CN(Cc3cccc(c3)C#N)C(=O)N2CC2CCC2)CC1)c1ccccc1 FULKUJGTRBNCGE-UHFFFAOYSA-N 0.000 claims 1
- KHVBGQXIDHWYFR-UHFFFAOYSA-N 3-[[1-(cyclobutylmethyl)-8-[ethyl(methyl)amino]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]methyl]benzonitrile Chemical compound CCN(C)C1(CCC2(CN(Cc3cccc(c3)C#N)C(=O)N2CC2CCC2)CC1)c1ccccc1 KHVBGQXIDHWYFR-UHFFFAOYSA-N 0.000 claims 1
- CZQIMPJTMOJZOC-UHFFFAOYSA-N 3-[[1-[(5-cyano-2-methoxyphenyl)methyl]-8-(dimethylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]methyl]-4-methoxybenzonitrile Chemical compound COc1ccc(cc1CN1CC2(CCC(CC2)(N(C)C)c2ccccc2)N(Cc2cc(ccc2OC)C#N)C1=O)C#N CZQIMPJTMOJZOC-UHFFFAOYSA-N 0.000 claims 1
- ZIWDDEMSWAXPOA-UHFFFAOYSA-N 3-[[8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]methyl]benzamide Chemical compound CN(C)C1(CCC2(CN(Cc3cccc(c3)C(N)=O)C(=O)N2CC2(O)CCC2)CC1)c1ccccc1 ZIWDDEMSWAXPOA-UHFFFAOYSA-N 0.000 claims 1
- DCYJVBMOSCLZEW-UHFFFAOYSA-N 3-benzyl-8-(dimethylamino)-1-ethyl-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound CCN1C(=O)N(Cc2ccccc2)CC11CCC(CC1)(N(C)C)c1ccccc1 DCYJVBMOSCLZEW-UHFFFAOYSA-N 0.000 claims 1
- UGMHTGXNTSNAJX-UHFFFAOYSA-N 3-benzyl-8-(dimethylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C1(CCC2(CN(C(N2)=O)CC2=CC=CC=C2)CC1)C1=CC=CC=C1)C UGMHTGXNTSNAJX-UHFFFAOYSA-N 0.000 claims 1
- 125000006275 3-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C([H])C(*)=C1[H] 0.000 claims 1
- YDBCFLZEMCMGGF-UHFFFAOYSA-N 4-[[1-(cyclobutylmethyl)-8-(dimethylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]methyl]benzamide Chemical compound CN(C)C1(CCC2(CN(Cc3ccc(cc3)C(N)=O)C(=O)N2CC2CCC2)CC1)c1ccccc1 YDBCFLZEMCMGGF-UHFFFAOYSA-N 0.000 claims 1
- OMKDSWPCDJXLHL-UHFFFAOYSA-N 4-[[8-(dimethylamino)-3-[(2-methoxyphenyl)methyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-1-yl]methyl]benzonitrile Chemical compound COc1ccccc1CN1CC2(CCC(CC2)(N(C)C)c2ccccc2)N(Cc2ccc(cc2)C#N)C1=O OMKDSWPCDJXLHL-UHFFFAOYSA-N 0.000 claims 1
- IIWPFIOGXDEILF-UHFFFAOYSA-N 8-(dimethylamino)-1,3-bis[(2-methoxyphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1ccccc1CN1CC2(CCC(CC2)(N(C)C)c2ccccc2)N(Cc2ccccc2OC)C1=O IIWPFIOGXDEILF-UHFFFAOYSA-N 0.000 claims 1
- IHTLAUCEENRUEU-UHFFFAOYSA-N 8-(dimethylamino)-1-(2,2-dimethylpropyl)-3-[(4-methoxyphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3ccccc3)N(CC(C)(C)C)C2=O)cc1 IHTLAUCEENRUEU-UHFFFAOYSA-N 0.000 claims 1
- CWNVRGJEWVHJCP-UHFFFAOYSA-N 8-(dimethylamino)-1-(2-hydroxy-2-methylpropyl)-3-[(4-methoxyphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3ccccc3)N(CC(C)(C)O)C2=O)cc1 CWNVRGJEWVHJCP-UHFFFAOYSA-N 0.000 claims 1
- JPPRWNMMGJNQBN-UHFFFAOYSA-N 8-(dimethylamino)-1-(2-hydroxyethyl)-3-[(4-methoxyphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C1(CCC2(CN(C(N2CCO)=O)CC2=CC=C(C=C2)OC)CC1)C1=CC=CC=C1)C JPPRWNMMGJNQBN-UHFFFAOYSA-N 0.000 claims 1
- SFVUCTQOKPNATA-UHFFFAOYSA-N 8-(dimethylamino)-1-(2-methoxy-2-methylpropyl)-3-[(4-methoxyphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C1(CCC2(CN(C(N2CC(C)(C)OC)=O)CC2=CC=C(C=C2)OC)CC1)C1=CC=CC=C1)C SFVUCTQOKPNATA-UHFFFAOYSA-N 0.000 claims 1
- QWTRCFJREFKNLA-UHFFFAOYSA-N 8-(dimethylamino)-1-(2-methoxyethyl)-3-[(4-methoxyphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound COCCN1C(=O)N(Cc2ccc(OC)cc2)CC11CCC(CC1)(N(C)C)c1ccccc1 QWTRCFJREFKNLA-UHFFFAOYSA-N 0.000 claims 1
- CZVLUFVYJXQKHZ-UHFFFAOYSA-N 8-(dimethylamino)-1-(3-hydroxy-3-methylbutyl)-3-[(4-methoxyphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3ccccc3)N(CCC(C)(C)O)C2=O)cc1 CZVLUFVYJXQKHZ-UHFFFAOYSA-N 0.000 claims 1
- SIGOICSVLIYHOG-UHFFFAOYSA-N 8-(dimethylamino)-1-(3-hydroxypropyl)-3-[(4-methoxyphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C1(CCC2(CN(C(N2CCCO)=O)CC2=CC=C(C=C2)OC)CC1)C1=CC=CC=C1)C SIGOICSVLIYHOG-UHFFFAOYSA-N 0.000 claims 1
- GABIRMYMQDJWCZ-UHFFFAOYSA-N 8-(dimethylamino)-1-(3-methoxy-3-methylbutyl)-3-[(4-methoxyphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3ccccc3)N(CCC(C)(C)OC)C2=O)cc1 GABIRMYMQDJWCZ-UHFFFAOYSA-N 0.000 claims 1
- KDLYBOULYFJNGG-UHFFFAOYSA-N 8-(dimethylamino)-1-(4-methoxybutyl)-3-[(4-methoxyphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C1(CCC2(CN(C(N2CCCCOC)=O)CC2=CC=C(C=C2)OC)CC1)C1=CC=CC=C1)C KDLYBOULYFJNGG-UHFFFAOYSA-N 0.000 claims 1
- HJGLMAHARWNVIB-UHFFFAOYSA-N 8-(dimethylamino)-1-(oxolan-3-ylmethyl)-8-phenyl-3-(pyrimidin-2-ylmethyl)-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C)C1(CCC2(CC1)CN(C(=O)N2CC3CCOC3)CC4=NC=CC=N4)C5=CC=CC=C5 HJGLMAHARWNVIB-UHFFFAOYSA-N 0.000 claims 1
- BDSLZNQEPZAZFZ-UHFFFAOYSA-N 8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-3-[(3-methoxyphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1cccc(CN2CC3(CCC(CC3)(N(C)C)c3ccccc3)N(CC3(O)CCC3)C2=O)c1 BDSLZNQEPZAZFZ-UHFFFAOYSA-N 0.000 claims 1
- NZNKTAQYGWAKRG-UHFFFAOYSA-N 8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-3-[[1-(2-hydroxyethyl)triazol-4-yl]methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C)C1(CCC2(CN(Cc3cn(CCO)nn3)C(=O)N2CC2(O)CCC2)CC1)c1ccccc1 NZNKTAQYGWAKRG-UHFFFAOYSA-N 0.000 claims 1
- SQVUGTPGSWROSO-UHFFFAOYSA-N 8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-8-phenyl-3-(1-phenylcyclopropyl)-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C)C1(CCC2(CN(C(=O)N2CC2(O)CCC2)C2(CC2)c2ccccc2)CC1)c1ccccc1 SQVUGTPGSWROSO-UHFFFAOYSA-N 0.000 claims 1
- VFVLDDWIJAMRTA-UHFFFAOYSA-N 8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-8-phenyl-3-(2-phenylethyl)-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C)C1(CCC2(CN(CCC3=CC=CC=C3)C(=O)N2CC2(O)CCC2)CC1)C1=CC=CC=C1 VFVLDDWIJAMRTA-UHFFFAOYSA-N 0.000 claims 1
- BOACSMICRXRONP-UHFFFAOYSA-N 8-(dimethylamino)-1-[(1-hydroxycyclopentyl)methyl]-3-[(4-methoxyphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C1(CCC2(CN(C(N2CC2(CCCC2)O)=O)CC2=CC=C(C=C2)OC)CC1)C1=CC=CC=C1)C BOACSMICRXRONP-UHFFFAOYSA-N 0.000 claims 1
- YHFRDHDYJQGFCO-UHFFFAOYSA-N 8-(dimethylamino)-1-[(1-methoxycyclobutyl)methyl]-3-[(4-methoxyphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3ccccc3)N(CC3(CCC3)OC)C2=O)cc1 YHFRDHDYJQGFCO-UHFFFAOYSA-N 0.000 claims 1
- FQWQSNXRVLAODG-QJYLRPAKSA-N 8-(dimethylamino)-1-[(2R)-2-hydroxypropyl]-3-[(4-methoxyphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3ccccc3)N(C[C@@H](C)O)C2=O)cc1 FQWQSNXRVLAODG-QJYLRPAKSA-N 0.000 claims 1
- FQWQSNXRVLAODG-HTFLBPPUSA-N 8-(dimethylamino)-1-[(2S)-2-hydroxypropyl]-3-[(4-methoxyphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C1(CCC2(CN(C(N2C[C@H](C)O)=O)CC2=CC=C(C=C2)OC)CC1)C1=CC=CC=C1)C FQWQSNXRVLAODG-HTFLBPPUSA-N 0.000 claims 1
- NMEIAEAEMHITNV-UHFFFAOYSA-N 8-(dimethylamino)-1-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]-3-[(4-methoxyphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound COCCOCCOCCOCCOCCOCCOCCOCCN1C(=O)N(Cc2ccc(OC)cc2)CC11CCC(CC1)(N(C)C)c1ccccc1 NMEIAEAEMHITNV-UHFFFAOYSA-N 0.000 claims 1
- YGKSGVSDBCEYFA-UHFFFAOYSA-N 8-(dimethylamino)-1-ethyl-3-[(4-methylsulfonylphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound CCN1C(=O)N(Cc2ccc(cc2)S(C)(=O)=O)CC11CCC(CC1)(N(C)C)c1ccccc1 YGKSGVSDBCEYFA-UHFFFAOYSA-N 0.000 claims 1
- LNOCBRQVXASBHM-UHFFFAOYSA-N 8-(dimethylamino)-1-hexyl-3-[(4-methoxyphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound CCCCCCN1C(=O)N(Cc2ccc(OC)cc2)CC11CCC(CC1)(N(C)C)c1ccccc1 LNOCBRQVXASBHM-UHFFFAOYSA-N 0.000 claims 1
- ZCLDCJBPOKYYLS-UHFFFAOYSA-N 8-(dimethylamino)-3-(2-imidazol-1-ylethyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C)C1(CCC2(CN(CCn3ccnc3)C(=O)N2)CC1)c1ccccc1 ZCLDCJBPOKYYLS-UHFFFAOYSA-N 0.000 claims 1
- BNKDNWQCAAKLJI-UHFFFAOYSA-N 8-(dimethylamino)-3-[(2-methoxyphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1ccccc1CN1CC2(CCC(CC2)(N(C)C)c2ccccc2)NC1=O BNKDNWQCAAKLJI-UHFFFAOYSA-N 0.000 claims 1
- HIASAFPALQTZIO-UHFFFAOYSA-N 8-(dimethylamino)-3-[(2-morpholin-4-ylpyridin-4-yl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C)C1(CCC2(CN(Cc3ccnc(c3)N3CCOCC3)C(=O)N2)CC1)c1ccccc1 HIASAFPALQTZIO-UHFFFAOYSA-N 0.000 claims 1
- IIXIYAOBXURUSH-UHFFFAOYSA-N 8-(dimethylamino)-3-[(3-methylsulfonylphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C)C1(CCC2(CN(Cc3cccc(c3)S(C)(=O)=O)C(=O)N2)CC1)c1ccccc1 IIXIYAOBXURUSH-UHFFFAOYSA-N 0.000 claims 1
- ZFDFQROBUBTCCD-UHFFFAOYSA-N 8-(dimethylamino)-3-[(4-methoxyphenyl)methyl]-1-(2-methylpropyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3ccccc3)N(CC(C)C)C2=O)cc1 ZFDFQROBUBTCCD-UHFFFAOYSA-N 0.000 claims 1
- FOGFBFFNNUETQN-UHFFFAOYSA-N 8-(dimethylamino)-3-[(4-methoxyphenyl)methyl]-1-(2-methylsulfinylethyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3ccccc3)N(CCS(C)=O)C2=O)cc1 FOGFBFFNNUETQN-UHFFFAOYSA-N 0.000 claims 1
- NBJAQPQZTRCRMT-UHFFFAOYSA-N 8-(dimethylamino)-3-[(4-methoxyphenyl)methyl]-1-(2-methylsulfonylethyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3ccccc3)N(CCS(C)(=O)=O)C2=O)cc1 NBJAQPQZTRCRMT-UHFFFAOYSA-N 0.000 claims 1
- BXZLRTCXNRQVCW-UHFFFAOYSA-N 8-(dimethylamino)-3-[(4-methoxyphenyl)methyl]-1-(3-methoxypropyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound COCCCN1C(=O)N(Cc2ccc(OC)cc2)CC11CCC(CC1)(N(C)C)c1ccccc1 BXZLRTCXNRQVCW-UHFFFAOYSA-N 0.000 claims 1
- KHOAUVUZRCUBHZ-UHFFFAOYSA-N 8-(dimethylamino)-3-[(4-methoxyphenyl)methyl]-1-(3-methylbutyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3ccccc3)N(CCC(C)C)C2=O)cc1 KHOAUVUZRCUBHZ-UHFFFAOYSA-N 0.000 claims 1
- YBCDTEYNGKTZQM-UHFFFAOYSA-N 8-(dimethylamino)-3-[(4-methoxyphenyl)methyl]-1-(oxan-4-ylmethyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3ccccc3)N(CC3CCOCC3)C2=O)cc1 YBCDTEYNGKTZQM-UHFFFAOYSA-N 0.000 claims 1
- BRGYSARXRNOOFN-UHFFFAOYSA-N 8-(dimethylamino)-3-[(4-methoxyphenyl)methyl]-1-(oxetan-3-ylmethyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3ccccc3)N(CC3COC3)C2=O)cc1 BRGYSARXRNOOFN-UHFFFAOYSA-N 0.000 claims 1
- RDBLEYJWOHZILJ-UHFFFAOYSA-N 8-(dimethylamino)-3-[(4-methoxyphenyl)methyl]-1-(oxolan-2-ylmethyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3ccccc3)N(CC3CCCO3)C2=O)cc1 RDBLEYJWOHZILJ-UHFFFAOYSA-N 0.000 claims 1
- RHAGFGQMVKOAOQ-UHFFFAOYSA-N 8-(dimethylamino)-3-[(4-methoxyphenyl)methyl]-1-[(1-methylcyclobutyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3ccccc3)N(CC3(C)CCC3)C2=O)cc1 RHAGFGQMVKOAOQ-UHFFFAOYSA-N 0.000 claims 1
- XEYHRCKUXCHABL-UHFFFAOYSA-N 8-(dimethylamino)-3-[(4-methoxyphenyl)methyl]-1-methyl-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3ccccc3)N(C)C2=O)cc1 XEYHRCKUXCHABL-UHFFFAOYSA-N 0.000 claims 1
- BHNBGYKHHFLUSJ-UHFFFAOYSA-N 8-(dimethylamino)-3-[(4-methoxyphenyl)methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C1(CCC2(CN(C(N2)=O)CC2=CC=C(C=C2)OC)CC1)C1=CC=CC=C1)C BHNBGYKHHFLUSJ-UHFFFAOYSA-N 0.000 claims 1
- IFVSSUYAYWQMML-UHFFFAOYSA-N 8-(dimethylamino)-3-[(4-methoxyphenyl)methyl]-8-phenyl-1-(pyridin-3-ylmethyl)-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3ccccc3)N(Cc3cccnc3)C2=O)cc1 IFVSSUYAYWQMML-UHFFFAOYSA-N 0.000 claims 1
- MMQCILBZQQKEQC-UHFFFAOYSA-N 8-(dimethylamino)-3-[(4-methoxyphenyl)methyl]-8-phenyl-1-(pyrimidin-4-ylmethyl)-1,3-diazaspiro[4.5]decan-2-one Chemical compound COC1=CC=C(CN2CC3(CCC(CC3)(N(C)C)C3=CC=CC=C3)N(CC3=CC=NC=N3)C2=O)C=C1 MMQCILBZQQKEQC-UHFFFAOYSA-N 0.000 claims 1
- ZDOKCQISPIJWSQ-UHFFFAOYSA-N 8-(dimethylamino)-3-[(4-methoxyphenyl)methyl]-8-phenyl-1-[3-(trifluoromethoxy)propyl]-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3ccccc3)N(CCCOC(F)(F)F)C2=O)cc1 ZDOKCQISPIJWSQ-UHFFFAOYSA-N 0.000 claims 1
- YKJRFMZLGSIQRX-UHFFFAOYSA-N 8-(dimethylamino)-3-[(4-methoxyphenyl)methyl]-8-phenyl-1-propan-2-yl-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3ccccc3)N(C(C)C)C2=O)cc1 YKJRFMZLGSIQRX-UHFFFAOYSA-N 0.000 claims 1
- SXFLFVXSZGMVAC-UHFFFAOYSA-N 8-(dimethylamino)-3-[(4-methoxyphenyl)methyl]-8-phenyl-1-propyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound CCCN1C(=O)N(Cc2ccc(OC)cc2)CC11CCC(CC1)(N(C)C)c1ccccc1 SXFLFVXSZGMVAC-UHFFFAOYSA-N 0.000 claims 1
- IHUFDVVXUQAUSC-UHFFFAOYSA-N 8-(dimethylamino)-3-[[1-(2-hydroxyethyl)triazol-4-yl]methyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C)C1(CCC2(CN(CC3=CN(CCO)N=N3)C(=O)N2)CC1)C1=CC=CC=C1 IHUFDVVXUQAUSC-UHFFFAOYSA-N 0.000 claims 1
- BGEAEALXBNWGJY-UHFFFAOYSA-N 8-(dimethylamino)-8-(3-fluorophenyl)-3-[(4-methoxyphenyl)methyl]-1,3-diazaspiro[4.5]decan-2-one Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3cccc(F)c3)NC2=O)cc1 BGEAEALXBNWGJY-UHFFFAOYSA-N 0.000 claims 1
- AJPXHRMJMSUXJS-UHFFFAOYSA-N 8-(dimethylamino)-8-phenyl-3-(1-phenylcyclopropyl)-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C)C1(CCC2(CN(C(=O)N2)C2(CC2)c2ccccc2)CC1)c1ccccc1 AJPXHRMJMSUXJS-UHFFFAOYSA-N 0.000 claims 1
- OYBWOVGHVZVZSD-UHFFFAOYSA-N 8-(dimethylamino)-8-phenyl-3-(2-phenylpropan-2-yl)-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C)C1(CCC2(CN(C(=O)N2)C(C)(C)c2ccccc2)CC1)c1ccccc1 OYBWOVGHVZVZSD-UHFFFAOYSA-N 0.000 claims 1
- JOLUVUVJNIWFLC-UHFFFAOYSA-N 8-(dimethylamino)-8-phenyl-3-(2-pyridin-2-ylethyl)-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C)C1(CCC2(CN(CCc3ccccn3)C(=O)N2)CC1)c1ccccc1 JOLUVUVJNIWFLC-UHFFFAOYSA-N 0.000 claims 1
- TZFZHFYOMZMELA-UHFFFAOYSA-N 8-(dimethylamino)-8-phenyl-3-(2-pyridin-3-ylethyl)-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C)C1(CCC2(CN(CCc3cccnc3)C(=O)N2)CC1)c1ccccc1 TZFZHFYOMZMELA-UHFFFAOYSA-N 0.000 claims 1
- DWJHZDSSTJTPDK-UHFFFAOYSA-N 8-(dimethylamino)-8-phenyl-3-(2-pyridin-4-ylethyl)-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C)C1(CCC2(CN(CCc3ccncc3)C(=O)N2)CC1)c1ccccc1 DWJHZDSSTJTPDK-UHFFFAOYSA-N 0.000 claims 1
- NZHXKLSTIAROEI-UHFFFAOYSA-N 8-(dimethylamino)-8-phenyl-3-(2-pyrimidin-5-ylethyl)-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C)C1(CCC2(CN(CCc3cncnc3)C(=O)N2)CC1)c1ccccc1 NZHXKLSTIAROEI-UHFFFAOYSA-N 0.000 claims 1
- PAYLTRHVQMVJST-UHFFFAOYSA-N 8-(dimethylamino)-8-phenyl-3-(pyridin-2-ylmethyl)-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C)C1(CCC2(CN(Cc3ccccn3)C(=O)N2)CC1)c1ccccc1 PAYLTRHVQMVJST-UHFFFAOYSA-N 0.000 claims 1
- GHQKTRSWBUIBJI-UHFFFAOYSA-N 8-(dimethylamino)-8-phenyl-3-(pyridin-3-ylmethyl)-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C)C1(CCC2(CN(Cc3cccnc3)C(=O)N2)CC1)c1ccccc1 GHQKTRSWBUIBJI-UHFFFAOYSA-N 0.000 claims 1
- AKWKGEGNFIIACQ-UHFFFAOYSA-N 8-(dimethylamino)-8-phenyl-3-(pyridin-4-ylmethyl)-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C)C1(CCC2(CN(Cc3ccncc3)C(=O)N2)CC1)c1ccccc1 AKWKGEGNFIIACQ-UHFFFAOYSA-N 0.000 claims 1
- HPKYSCFZZQFEJG-UHFFFAOYSA-N 8-(dimethylamino)-8-phenyl-3-(triazolidin-4-ylmethyl)-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C)C1(CCC2(CC1)CN(C(=O)N2)CC3CNNN3)C4=CC=CC=C4 HPKYSCFZZQFEJG-UHFFFAOYSA-N 0.000 claims 1
- MWMHYYGHXIKTQX-UHFFFAOYSA-N 8-(dimethylamino)-8-phenyl-3-[(2-piperazin-1-ylpyridin-4-yl)methyl]-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C)C1(CCC2(CN(Cc3ccnc(c3)N3CCNCC3)C(=O)N2)CC1)c1ccccc1 MWMHYYGHXIKTQX-UHFFFAOYSA-N 0.000 claims 1
- ROIMBMRNONGKDW-UHFFFAOYSA-N 8-(dimethylamino)-8-phenyl-3-[(2-piperidin-1-ylpyridin-4-yl)methyl]-1,3-diazaspiro[4.5]decan-2-one Chemical compound CN(C)C1(CCC2(CN(Cc3ccnc(c3)N3CCCCC3)C(=O)N2)CC1)c1ccccc1 ROIMBMRNONGKDW-UHFFFAOYSA-N 0.000 claims 1
- 239000005711 Benzoic acid Substances 0.000 claims 1
- HIPWFIJDSIDRID-UHFFFAOYSA-N N-(cyanomethyl)-2-[8-(dimethylamino)-3-[(4-methoxyphenyl)methyl]-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-1-yl]acetamide Chemical compound COc1ccc(CN2CC3(CCC(CC3)(N(C)C)c3ccccc3)N(CC(=O)NCC#N)C2=O)cc1 HIPWFIJDSIDRID-UHFFFAOYSA-N 0.000 claims 1
- WEVYAHXRMPXWCK-UHFFFAOYSA-N acetonitrile Substances CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 1
- 235000010233 benzoic acid Nutrition 0.000 claims 1
- 150000001735 carboxylic acids Chemical class 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- UOQACRNTVQWTFF-UHFFFAOYSA-N decane-1,10-dithiol Chemical compound SCCCCCCCCCCS UOQACRNTVQWTFF-UHFFFAOYSA-N 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 229940080818 propionamide Drugs 0.000 claims 1
- 235000019260 propionic acid Nutrition 0.000 claims 1
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 125000001425 triazolyl group Chemical group 0.000 claims 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Claims (15)
1. Spoj prema općoj formuli (I)
[image]
gdje
n označava 1, 2 ili 3;
R1 i R2 međusobno neovisno označavaju
-H;
-C1-C6-alkil, linearni ili razgranati, zasićeni ili nezasićeni, nesupstituiran ili supstituiran sa jednim, dva, tri ili četiri supstituenta međusobno neovisno izabrana iz grupe koja se sastoji od -F, -Cl, -Br, -I, -OH, -OCH3, -CN i -CO2CH3;
3-12-članu cikloalkil grupu, zasićenu ili nezasićenu, nesupstituiranu ili supstituiranu sa jednim, dva, tri ili četiri supstituenta međusobno neovisno izabrana iz grupe koja se sastoji od -F, -Cl, -Br, -I, -OH, -OCH3, -CN i -CO2CH3; gdje je navedena 3-12-člana cikloalkil grupa izborno vezana preko -C1-C6-alkilena-, linearnog ili razgranatog, zasićenog ili nezasićenog, nesupstituiranog; ili
3-12-članu heterocikloalkil grupu, zasićenu ili nezasićenu, nesupstituiranu ili supstituiranu sa jednim, dva, tri ili četiri supstituenta međusobno neovisno izabrana iz grupe koja se sastoji od -F, -Cl, -Br, -I, -OH, -OCH3, -CN i -CO2CH3; gdje je navedena 3-12-člana heterocikloalkil grupa izborno vezana preko -C1-C6-alkilena-, linearnog ili razgranatog, zasićenog ili nezasićenog, nesupstituiranog;
ili
R1 i R2 zajedno sa atomom dušika za koji su vezani formiraju prsten i označavaju -(CH2)3-6-;-(CH2)2-O-(CH2)2-; ili -(CH2)2-NRA-(CH2)2-, gdje RA označava -H ili -C1-C6-alkil, linearni ili razgranati, zasićeni ili nezasićeni, nesupstituiran ili supstituiran sa jednim, dva, tri ili četiri supstituenta međusobno neovisno izabrana iz grupe koja se sastoji od -F, -Cl, -Br i -I;
R3 označava
-C1-C6-alkil, linearni ili razgranati, zasićeni ili nezasićeni, nesupstituiran, mono- ili polisupstituiran;
3-12-članu cikloalkil grupu, zasićenu ili nezasićenu, nesupstituiranu, mono- ili polisupstituiranu; gdje je navedena 3-12-člana cikloalkil grupa izborno vezana preko -C1-C6-alkilena-, linearnog ili razgranatog, zasićenog ili nezasićenog, nesupstituiranog, mono- ili polisupstituiranog;
3-12-članu heterocikloalkil grupu, zasićenu ili nezasićenu, nesupstituiranu, mono- ili polisupstituiranu; gdje je navedena 3-12-člana heterocikloalkil grupa izborno vezana preko -C1-C6-alkilena-, linearnog ili razgranatog, zasićenog ili nezasićenog, nesupstituiranog, mono- ili polisupstituiranog;
6-14-članu aril grupu, nesupstituiranu, mono- ili polisupstituiranu; gdje je navedena 6-14-člana aril grupa izborno vezana preko -C1-C6-alkilena-, linearnog ili razgranatog, zasićenog ili nezasićenog, nesupstituiranog, mono- ili polisupstituiranog; ili
5-14-članu heteroaril grupu, nesupstituiranu, mono- ili polisupstituiranu; gdje je navedena 5-14-člana heteroaril grupa izborno vezana preko -C1-C6-alkilena-, linearnog ili razgranatog, zasićenog ili nezasićenog, nesupstituiranog, mono- ili polisupstituiranog;
R4 označava
-H;
-C1-C6-alkil, linearni ili razgranati, zasićeni ili nezasićeni, nesupstituiran, mono- ili polisupstituiran; gdje je navedeni -C1-C6-alkil izborno vezan preko -C(=O)-, -C(=O)O- ili -S(=O)2-;
3-12-članu cikloalkil grupu, zasićenu ili nezasićenu, nesupstituiranu, mono- ili polisupstituiranu; gdje je navedena 3-12-člana cikloalkil grupa izborno vezana preko -C1-C6-alkilena-, linearnog ili razgranatog, zasićenog ili nezasićenog, nesupstituiranog, mono- ili polisupstituiranog; ili gdje je navedena 3-12-člana cikloalkil grupa izborno vezana preko -C(=O)-, -C(=O)O-, -C(=O)O-CH2-, ili -S(=O)2-;
3-12-članu heterocikloalkil grupu, zasićenu ili nezasićenu, nesupstituiranu, mono- ili polisupstituiranu; gdje je navedena 3-12-člana heterocikloalkil grupa izborno vezana preko -C1-C6-alkilena-, linearnog ili razgranatog, zasićenog ili nezasićenog, nesupstituiranog, mono- ili polisupstituiranog; ili gdje je navedena 3-12-člana heterocikloalkil grupa izborno vezana preko -C(=O)-, -C(=O)O-, -C(=O)O-CH2- ili -S(=O)2-;
6-14-članu aril grupu, nesupstituiranu, mono- ili polisupstituiranu; gdje je navedena 6-14-člana aril grupa izborno vezana preko -C1-C6-alkilena-, linearnog ili razgranatog, zasićenog ili nezasićenog, nesupstituiranog, mono- ili polisupstituiranog; ili gdje je navedena 6-14-člana aril grupa izborno vezana preko -C(=O)-, -C(=O)O-, -C(=O)O-CH2- ili -S(=O)2-; ili
5-14-članu heteroaril grupu, nesupstituiranu, mono- ili polisupstituiranu; gdje je navedena 5-14-člana heteroaril grupa izborno vezana preko -C1-C6-alkilena-, linearnog ili razgranatog, zasićenog ili nezasićenog, nesupstituiranog, mono- ili polisupstituiranog; ili gdje je navedena 5-14-člana heteroaril grupa izborno vezana preko -C(=O)-, -C(=O)O-, -C(=O)O-CH2- ili -S(=O)2-;
R5 označava
6-14-članu aril grupu, nesupstituiranu, mono- ili polisupstituiranu; ili
5-14-članu heteroaril grupu, nesupstituiranu, mono- ili polisupstituiranu;
R7, R8, R11, R12, R13, R14, R15, R16, R17, R18, R19 i R20 međusobno neovisno označavaju -H, -F, -Cl, -Br, -I, -OH ili -C1-C6-alkil, linearni ili razgranati, zasićeni ili nezasićeni, nesupstituiran, mono- ili polisupstituiran;
ili gdje R7 i R8 zajedno sa atomom ugljika za koji su vezani formiraju prsten i označavaju -(CH2)2- ili -(CH2)3-;
gdje "mono- ili polisupstituiran" označava da su jedan ili više atoma vodika zamijenjeni supstituentom međusobno neovisno izabranim iz grupe koja se sastoji od -F, -Cl, -Br, -I, -CN, -R21, -C(=O)R21, -C(=O)OR21, -C(=O)NR21R22, -O-(CH2CH2-O)1-30-H, -O-(CH2CH2-O)1-30-CH3, =O, -OR21, -OC(=O)R21, -OC(=O)OR21, -OC(=O)NR21R22, -NO2, -NR21R22, -NR21-(CH2)1-6-C(=O)R22, -NR21-(CH2)1-6-C(=O)OR22, -NR23-(CH2)1-6-C(=O)NR21R22, -NR21C(=O)R22, -NR21C(=O)-OR22, -NR23C(=O)NR21R22, -NR21S(=O)2R22, -SR21, -S(=O)R21, -S(=O)2R21, -S(=O)2OR21 i -S(=O)2NR21R22;
gdje
R21, R22 i R23 međusobno neovisno označavaju
-H;
-C1-C6-alkil, linearni ili razgranati, zasićeni ili nezasićeni, nesupstituiran ili supstituiran sa jednim, dva, tri ili četiri supstituenta međusobno neovisno izabrana iz grupe koja se sastoji od -F, -Cl, -Br, -I, -CN, -OH, -NH2 i -O-C1-C6-alkila;
3-12-članu cikloalkil grupu, zasićenu ili nezasićenu, nesupstituiranu; gdje je navedena 3-12-člana cikloalkil grupa izborno vezana preko -C1-C6-alkilena-, linearnog ili razgranatog, zasićenog ili nezasićenog, nesupstituiranog ili supstituiranog sa jednim, dva, tri ili četiri supstituenta međusobno neovisno izabrana iz grupe koja se sastoji od -F, -Cl, -Br, -I, -CN, -OH, -NH2, -C1-C6-alkil i -O-C1-C6-alkila;
3-12-članu heterocikloalkil grupu, zasićenu ili nezasićenu, nesupstituiranu; gdje je navedena 3-12-člana heterocikloalkil grupa izborno vezana preko -C1-C6-alkilena-, linearnog ili razgranatog, zasićenog ili nezasićenog, nesupstituiranog ili supstituiranog sa jednim, dva, tri ili četiri supstituenta međusobno neovisno izabrana iz grupe koja se sastoji od -F, -Cl, -Br, -I, -CN, -OH, -NH2, -C1-C6-alkil i -O-C1-C6-alkil;
6-14-članu aril grupu, nesupstituiranu, mono- ili polisupstituiranu; gdje je navedena 6-14-člana aril grupa izborno vezana preko -C1-C6-alkilena-, linearnog ili razgranatog, zasićenog ili nezasićenog, nesupstituiranog ili supstituiranog sa jednim, dva, tri ili četiri supstituenta međusobno neovisno izabrana iz grupe koja se sastoji od -F, -Cl, -Br, -I, -CN, -OH, -NH2, -C1-C6-alkil i -O-C1-C6-alkila;
5-14-članu heteroaril grupu, nesupstituiranu, mono- ili polisupstituiranu; gdje je navedena 5-14-člana heteroaril grupa izborno vezana preko -C1-C6-alkilena-, linearnog ili razgranatog, zasićenog ili nezasićenog, nesupstituiranog ili supstituiranog sa jednim, dva, tri ili četiri supstituenta međusobno neovisno izabrana iz grupe koja se sastoji od -F, -Cl, -Br, -I, -CN, -OH, -NH2, -C1-C6-alkil i -O-C1-C6-alkila;
ili R21 i R22 unutar -C(=O)NR21R22, -OC(=O)NR21R22, -NR21R22, -NR23-(CH2)1-6-C(=O)NR21R22, -NR23C(=O)NR21W22, ili -S(=O)2NR21R22 zajedno sa atomom dušika za koji su vezani formiraju prsten i označavaju -(CH2)3-6-; -(CH2)2-O-(CH2)2-; ili -(CH2)2-NRB-(CH2)2-, gdje RB označava -H ili -C1-C6-alkil, linearni ili razgranati, zasićeni ili nezasićeni, nesupstituiran ili supstituiran sa jednim, dva, tri ili četiri supstituenta međusobno neovisno izabrana iz grupe koja se sastoji od -F, -Cl, -Br i -I;
ili njegova farmaceutski prihvatljiva sol.
2. Spoj prema patentnom zahtjevu 1, naznačen time što R7, R8, R11, R12, R13, R14, R15, R16, R17, R18, R19 i R20 međusobno neovisno označavaju -H, -F, -OH ili -C1-C6-alkil; ili R7 i R8 zajedno sa atomom ugljika za koji su vezani formiraju prsten i označavaju -(CH2)2-.
3. Spoj prema patentnom zahtjevu 1 ili 2, naznačen time što (i) R1 označava -H; i R2 označava -C1-C6-alkil, linearni ili razgranati, zasićeni ili nezasićeni, nesupstituiran, mono- ili polisupstituiran; ili (ii) R1 označava -CH3; i R2 označava -C1-C6-alkil, linearni ili razgranati, zasićeni ili nezasićeni, nesupstituiran, mono- ili polisupstituiran; ili (iii) R1 označava -H ili -CH3; i gdje R2 označava -CH2-cikloalkil, -CH2-ciklobutil-, -CH2-ciklopentil, -CH2-oksetanil ili -CH2-tetrahidrofuranil; ili (iv) R1 i R2 zajedno sa atomom dušika za koji su vezani formiraju prsten i označavaju -(CH2)3-6-.
4. Spoj prema bilo kojem od prethodnih patentnih zahtjeva, naznačen time što (i) R3 označava -C1-C6-alkil, linearni ili razgranati, zasićeni ili nezasićeni, nesupstituiran, mono- ili polisupstituiran; ili (ii) R3 označava 6-14-članu aril grupu, nesupstituiranu, mono- ili polisupstituiranu; ili (iii) R3 označava 5-14-članu heteroaril grupu, nesupstituiranu, mono- ili polisupstituiranu.
5. Spoj prema bilo kojem od prethodnih patentnih zahtjeva, naznačen time što (i) R4 označava -H; ili (ii) R4 označava -C1-C6-alkil, linearni ili razgranati, zasićeni ili nezasićeni, nesupstituiran, mono- ili polisupstituiran; ili (iii) R4 označava 3-12-članu cikloalkil grupu, zasićenu ili nezasićenu, nesupstituiranu, mono- ili polisupstituiranu; gdje je 3-12-člana cikloalkil grupa vezana preko -C1-C6-alkilena-, linearnog ili razgranatog, zasićenog ili nezasićenog, nesupstituiranog, mono- ili polisupstituiranog; ili (iv) R4 označava 3-12-članu heterocikloalkil grupu, zasićenu ili nezasićenu, nesupstituiranu, mono- ili polisupstituiranu; gdje je navedena 3-12-člana heterocikloalkil grupa vezana preko -C1-C6-alkilena-, linearnog ili razgranatog, zasićenog ili nezasićenog, nesupstituiranog, mono- ili polisupstituiranog; ili (v) R4 označava 6-14-članu aril grupu, nesupstituiranu, mono- ili polisupstituiranu; gdje je navedena 6-14-člana aril grupa vezana preko -C1-C6-alkilena-, linearnog ili razgranatog, zasićenog ili nezasićenog, nesupstituiranog, mono- ili polisupstituiranog; ili (vi) R4 označava 5-14-članu heteroaril grupu, nesupstituiranu, mono- ili polisupstituiranu; gdje je navedena 5-14-člana heteroaril grupa vezana preko -C1-C6-alkilena-, linearnog ili razgranatog, zasićenog ili nezasićenog, nesupstituiranog, mono- ili polisupstituiranog.
6. Spoj prema bilo kojem od prethodnih patentnih zahtjeva, naznačen time što n označava 1 ili 2.
7. Spoj prema bilo kojem od prethodnih patentnih zahtjeva, naznačen time što (i) R5 označava fenil, nesupstituiran, mono- ili polisupstituiran; ili (ii) R5 označava -pirazinil, -piridazinil, -piridinil, -pirimidinil, -tienil, -imidazolil, -triazolil ili -1,3-benzodioksolil u svakom slučaju nesupstituiran, mono- ili polisupstituiran.
8. Spoj prema bilo kojem od prethodnih patentnih zahtjeva, koji ima strukturu prema bilo kojoj od općih formula (II-A) do (VIII-C):
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
gdje u svakom slučaju
R1, R2, R3, R4 i R5 su definirani kao u bilo kojem od prethodnih patentnih zahtjeva,
RC označava -H, -OH, -F, -CN ili -C1-C4-alkil;
RD označava -H ili -F;
ili njegova farmaceutski prihvatljiva sol.
9. Spoj prema bilo kojem od prethodnih patentnih zahtjeva, naznačen time što R5 je izabran iz grupe koja se sastoji od:
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
[image]
10. Spoj prema bilo kojem od prethodnih patentnih zahtjeva, gdje
n označava 1 ili 2;
R1 označava -H ili -CH3;
R2 označava -H ili -C1-C6-alkil, linearni ili razgranati, zasićen ili nezasićen, nesupstituiran ili monosupstituiran sa -OH, -OCH3, -C(=O)OCH3, ili -CN;
R3 označava
-C1-C4-alkil, izborno monosupstituiran sa -OCH3;
-fenil, -tienil ili -piridinil, u svakom slučaju nesupstituiran ili supstituiran sa jednim, dva, tri ili četiri supstituenta međusobno neovisno izabrana iz grupe koja se sastoji od -F, -Cl, -CN, -CH3, -CH2CH3, -CH2F, -CHF2, -CF3, -OCF3, -OH, -OCH3, -O-CH2-O-CH3, -C(=O)NH2, C(=O)NHCH3, -C(=O)N(CH3)2, -NH2, -NHCH3, -N(CH3)2, -NHC(=O)CH3, -CH2OH, SOCH3 i SO2CH3; ili
R4 označava
-H;
-C1-C6-alkil, linearni ili razgranati, zasićen, nesupstituiran ili supstituiran sa jednim, dva, tri ili četiri supstituenta međusobno neovisno izabrana iz grupe koja se sastoji od -F, -Cl, -Br, -I, -CN, =O, -OH, -O-C1-C4-alkila, -CO2H, -C(=O)O-C1-C4-alkila, -C(=O)NH2, -C(=O)NH-C1-C4-alkila, -C(=O)N(C1-C4-alkil)2, -C(=O)NH-C1-C4-alkil-CN, -C(=O)NCH3-C1-C4-alkil-CN, -C(=O)NH-ciklopropil-CN, -C(=O)NCH3-ciklopropil-CN, -C(=O)NH-C1-C4-alkil-OH, -C(=O)NCH3-C1-C4-alkil-OH, -C(=O)NH-C1-C4-alkil-OCH3, -C(=O)NCH3-C1-C4-alkil-OCH3, -C(=O)NRR' gdje R i R' zajedno sa atomom dušika za koji su vezani formiraju prsten i označavaju -(CH2)2-4-;
3-6-člani cikloalkil, nesupstituiran ili supstituiran sa jednim, dva, tri ili četiri supstituenta međusobno neovisno izabrana iz grupe koja se sastoji od -F, -Cl, -Br, -I, -CN, -OH i -O-C1-C4-alkila, gdje je navedeni 3-6-člani cikloalkil vezan preko -C1-C6-alkilena;
3-6-člani heterocikloalkil, nesupstituiran ili supstituiran sa jednim, dva, tri ili četiri supstituenta međusobno neovisno izabrana iz grupe koja se sastoji od -F, -Cl, -Br, -I, -CN, -CO2H, -C(=O)O-C1-C4-alkila, -OH i -O-C1-C4-alkila, gdje je navedeni 3-6-člani heterocikloalkil vezan preko -C1-C6-alkilena;
6-14-člani aril, nesupstituiran ili supstituiran sa jednim, dva, tri ili četiri supstituenta međusobno neovisno izabrana iz grupe koja se sastoji od -F, -Cl, -Br, -I, -CN, -CO2H, -C(=O)O-C1-C4-alkila, -OH i -O-C1-C4-alkila; gdje je navedeni 6-14-člani aril vezan preko -C1-C6-alkilena- ili -S(=O)2-;
5-14-člani heteroaril, nesupstituiran ili supstituiran sa jednim, dva, tri ili četiri supstituenta međusobno neovisno izabrana iz grupe koja se sastoji od -F, -Cl, -Br, -I, -CN, -CO2H, -C(=O)O-C1-C4-alkila, -OH i -O-C1-C4-alkila; gdje je navedeni 5-14-člani heteroaril vezan preko -C1-C6-alkilena- ili -S(=O)2-;
R5 označava -fenil, -pirazinil, -piridazinil, -piridinil, -pirimidinil, -tienil, -imidazolil, triazolil ili -1,3-benzodioksolil, u svakom slučaju nesupstituiran ili supstituiran sa jednim, dva, tri ili četiri supstituenta međusobno neovisno izabrana iz grupe koja se sastoji od -F; -Cl; -Br; -I; -CN; -OH; -C1-C4-alkil; -CF3; -C1-C4-alkil-OH; -C1-C4-alkil-C(=O)NH2; -3-12-člani cikloalkil, zasićen ili nezasićen, nesupstituiran, mono- ili polisupstituiran; poželjno -ciklopropil, zasićen, nesupstituiran; -3-12-člani heterocikloalkil, zasićen ili nezasićen, nesupstituiran, mono- ili polisupstituiran; -O-CH2-O-; -O-C1-C4-alkil; -O-(CH2CH2-O)1-30-H; -O-(CH2CH2-O)1-30-CH3; -C(=O)OH; -C(=O)OC1-C4-alkil; -C(=O)NH2; -C(=O)NHC1-C4-alkil; -C(=O)N(C1-C4-alkil)2; -SC1-C4-alkil; -S(=O)C1-C4-alkil i -S(=O)2C1-C4-alkil; i
R7, R8, R11, R12, R13, R14, R15, R16, R17, R18, R19 i R20 označavaju -H.
11. Spoj prema bilo kojem od prethodnih patentnih zahtjeva, koji ima (i) strukturu prema općoj formuli (I')
[image]
gdje R1 do R5, R7, R8, R10 do R20 i n su definirani kao u bilo kojem od prethodnih patentnih zahtjeva,
ili njegova farmaceutski prihvatljiva sol; ili (ii) koji ima strukturu prema općoj formuli (IX)
[image]
gdje
RC označava -H ili -OH;
R3 označava -fenil ili -3-fluorofenil; i
R5 označava
6-14-člani aril, nesupstituiran, mono- ili polisupstituiran; ili
5-14-člani heteroaril, nesupstituiran, mono- ili polisupstituiran;
ili njegova farmaceutski prihvatljiva sol.
12. Spoj prema stavki (ii) patentnog zahtjeva 11, naznačen time što R5 je izabran od -fenila, -piridila, pirimidinila ili -triazolila, u svakom slučaju nesupstituiranog, mono- ili polisupstituiranog.
13. Spoj prema bilo kojem od prethodnih patentnih zahtjeva, koji je izabran iz grupe koja se sastoji od sljedećih
CIS-1-(Ciklobutil-metil)-8-dimetilamino-3-[(4-metilsulfonil-fenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-1-(Ciklobutil-metil)-8-dimetilamino-3-[(3-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-1-izopropil-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-1-(Ciklopropil-metil)-8-dimetilamino-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-1-(Ciklobutil-metil)-3-[(4-metoksifenil)-metil]-8-[metil-(2-metil-propil)-amino]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-2-[[1-(Ciklobutil-metil)-8-dimetilamino-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-3-il]-metil]-benzamid;
CIS-1-(Ciklobutil-metil)-8-dimetilamino-8-fenil-3-(pirazin-2-il-metil)-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-(Alil-metil-amino)-1-(ciklobutil-metil)-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-4-[[1-(Ciklobutil-metil)-8-dimetilamino-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-3-il]-metil]-benzamid;
CIS-1-(Ciklobutil-metil)-8-dimetilamino-8-(3-fluorofenil)-3-[(4-metoksifenil)-metil]-1,3-diazaspiro[4.5]dekan-2-on;
CIS-1-(Ciklobutil-metil)-8-dimetilamino-8-(4-fluorofenil)-3-[(4-metoksifenil)-metil]-1,3-diazaspiro[4.5]dekan-2-on;
CIS-1-(Ciklobutil-metil)-8-dimetilamino-8-(3-metoksifenil)-3-[(4-metoksifenil)-metil]-1,3-diazaspiro[4.5]dekan-2-on;
CIS-1-(Ciklobutil-metil)-8-dimetilamino-8-(4-metoksifenil)-3-[(4-metoksifenil)-metil]-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-3-[(4-metoksifenil)-metil]-1-(2-metil-propil)-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-1-Butil-8-dimetilamino-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-8-(4-fluorofenil)-3-[(4-metoksifenil)-metil]-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-8-(3-fluorofenil)-3-[(4-metoksifenil)-metil]-1,3-diazaspiro[4.5]dekan-2-on;
CIS-1-(Ciklobutil-metil)-8-dimetilamino-8-(3-hidroksifenil)-3-[(4-metoksifenil)-metil]-1,3-diazaspiro[4.5]dekan-2-on;
CIS-1-(Ciklobutil-metil)-8-dimetilamino-8-fenil-3-(piridin-3-il-metil)-1,3-diazaspiro[4.5]dekan-2-on;
CIS-1-(Ciklobutil-metil)-8-dimetilamino-3-[[3-[2-[2-[2-[2-[2-(2-metoksi-etoksi)-etoksi]-etoksi]-etoksi]-etoksi]-etoksi]-fenil]-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-1-(Ciklobutil-metil)-8-dimetilamino-8-(4-hidroksifenil)-3-[(4-metoksifenil)-metil]-1,3-diazaspiro[4.5]dekan-2-on hidroklorid;
CIS-8-Dimetilamino-1-[(1-hidroksi-ciklobutil)-metil]-3-[(3-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-1-(Ciklopentil-metil)-8-dimetilamino-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-1-(2-hidroksi-2-metil-propil)-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-1-(2-metoksi-2-metil-propil)-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-1-(Ciklobutil-metil)-3-[(3-metoksifenil)-metil]-8-metilamino-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-3-[[1-(Ciklobutil-metil)-8-(etil-metil-amino)-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-3-il]-metil]-benzonitril;
CIS-1-(Ciklobutil-metil)-3-[(3-metoksifenil)-metil]-8-(metil-propil-ammo)-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-1-(Ciklobutil-metil)-8-(etil-metil-ammo)-3-[(3-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-3-[8-Dimetilamino-3-[(4-metoksifenil)-metil]-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-1-il]-propionitril;
CIS-1-(Ciklobutil-metil)-8-metilamino-8-fenil-3-(piridin-3-il-metil)-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-3-[(4-metoksifenil)-metil]-1-(oxetan-3-il-metil)-8-fenil-1,3-diazaspiro-[4.5]dekan-2-on;
CIS-1-(Ciklobutil-metil)-8-(etil-metil-amino)-8-fenil-3-(piridin-3-il-metil)-1,3-diazaspiro-[4.5]dekan-2-on;
CIS-8-Dimetilamino-1-(2-hidroksi-etil)-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-1-(2,2-dimetil-propil)-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-3-[(4-metoksifenil)-metil]-1-(3-metil-butil)-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-3-[(4-metoksifenil)-metil]-8-fenil-1-[3-(trifluorometiloksi)-propil]-1,3-diazaspiro[4.5]dekan-2-on;
CIS-1-(2-Ciklobutil-etil)-8-dimetilamino-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-1-[(3,3-Difluoro-ciklobutil)-metil]-8-dimetilamino-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-2-[[1-(Ciklobutil-metil)-3-[(4-metoksifenil)-metil]-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-8-il]-metil-amino]-acetonitril;
CIS-1-(Ciklobutil-metil)-8-[(2-metoksi-etil)-metil-amino]-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-2-[8-Dimetilamino-3-[(4-metoksifenil)-metil]-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-1-il]- tert-Butil ester octene kiseline;
CIS-2-[8-Dimetilamino-3-[(4-metoksifenil)-metil]-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-1-il]- octene kiseline; sol 2,2,2-trifluoro-octene kiseline;
CIS-1-(Ciklobutil-metil)-3-[(4-metoksifenil)-metil]-8-metilammo-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-2-[8-Dimetilamino-3-[(4-metoksifenil)-metil]-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-1-il]- metil ester octene kiseline;
CIS-2-[8-Dimetilamino-3-[(4-metoksifenil)-metil]-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-1-il]-acetamid;
CIS-1-Benzil-8-dimetilamino-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-2-[8-Dimetilamino-3-[(4-metoksifenil)-metil]-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-1-il]-N-metil-acetamid;
CIS-2-[8-Dimetilamino-3-[(4-metoksifenil)-metil]-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-1-il]-N-propil-acetamid;
CIS-8-Dimetilamino-3-[(4-metoksifenil)-metil]-1-(3-metoksi-propil)-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-1-[(1-hidroksi-ciklobutil)-metil]-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-1-(2-metoksi-etil)-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-2-[8-Dimetilamino-3-[(4-metoksifenil)-metil]-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-1-il]-acetonitril;
CIS-8-Dimetilamino-1-heksil-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-3-[(4-metoksifenil)-metil]-8-fenil-1-(tetrahidro-piran-4-il-metil)-1,3-diazaspiro[4.5]dekan-2-on;
CIS-1-(Cikloheksil-metil)-8-dimetilamino-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-N-(Cijano-metil)-2-[8-dimetilamino-3-[(4-metoksifenil)-metil]-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-1-il]-acetamid;
CIS-8-Dimetilamino-3-[(4-metoksifenil)-metil]-8-fenil-1-(piridin-3-il-metil)-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-3-[(4-metoksifenil)-metil]-8-(3-metoksi-propil)-1,3-diazaspiro[4.5]dekan-2-on;
CIS-2-[8-Dimetilamino-3-[(4-metoksifenil)-metil]-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-1-il]-N-(2-metoksi-etil)-acetamid;
CIS-8-Dimetilamino-3-[(4-metoksifenil)-metil]-1-(2-okso-2-pirolidin-1-il-etil)-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-2-[8-Dimetilamino-3-[(4-metoksifenil)-metil]-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-1-il]-N,N-dimetil-acetamid;
CIS-N-(1-Cijano-ciklopropil)-2-[8-dimetilamino-3-[(4-metoksifenil)-metil]-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-1-il]-acetamid;
CIS-2-[8-Dimetilamino-3-[(4-metoksifenil)-metil]-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-1-il]-N-metil-N-propil-acetamid;
CIS-1-(Ciklobutil-metil)-8-dimetilamino-3-[(4-metoksifenil)-metil]-8-(3-metoksi-propil)-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-1-(3-hidroksi-propil)-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-1-(4-metoksi-butil)-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-3-[(4-metoksifenil)-metil]-1-[(1-metil-ciklobutil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-1-[(1-hidroksi-cikloheksil)-metil]-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-5-[8-Dimetilamino-3-[(4-metoksifenil)-metil]-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-1-il]-pentan nitril;
CIS-3-[8-Dimetilamino-3-[(4-metoksifenil)-metil]-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-1-il]-propionamid;
CIS-1-(Ciklobutil-metil)-8-[(2-hidroksi-etil)-metil-amino]-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-1-[[8-Dimetilamino-3-[(4-metoksifenil)-metil]-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-1-il]-metil]-ciklobutan-1-karbonitril;
CIS-8-Dimetilamino-1-[(1-hidroksi-ciklopentil)-metil]-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-3-[(2-Bromofenil)-metil]-1-(ciklobutil-metil)-8-dimetilamino-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-3-[8-Dimetilamino-3-[(4-metoksifenil)-metil]-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-1-il]-N-metil-propionamid;
CIS-3-[8-Dimetilamino-3-[(4-metoksifenil)-metil]-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-1-il]-N-propil-propionamid;
CIS-8-Dimetilamino-1-[(1-fluoro-ciklobutil)-metil]-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-1-(2-Cikloheksil-etil)-8-dimetilamino-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-3-[[1-(Ciklobutil-metil)-8-dimetilamino-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-3-il]-metil]-benzonitril;
CIS-8-Dimetilamino-3-[(4-metoksifenil)-metil]-1-metil-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-1-[2-[2-[2-[2-[2-[2-[2-(2-metoksi-etoksi)-etoksi]-etoksi]-etoksi]-etoksi]-etoksi]-etoksi]-etil]-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-3-[(4-metoksifenil)-metil]-8-fenil-1-(2-tetrahidro-piran-4-il-etil)-1,3-diazaspiro[4.5]dekan-2-on;
CIS-4-[[1-(Ciklobutil-metil)-8-dimetilamino-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-3-il]-metil]-benzonitril;
CIS-1-(Ciklobutil-metil)-8-dimetilamino-8-fenil-3-[[6-(trifluorometil)-piridin-3-il]-metil]-1,3-diazaspiro[4.5]dekan-2-on;
CIS-1-(Ciklobutil-metil)-8-dimetilamino-3-[[4-[2-[2-[2-[2-[2-[2-[2-(2-metoksi-etoksi)-etoksi]-etoksi]-etoksi]-etoksi]-etoksi]-etoksi]-etoksi]-fenil]-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-3-[[1-(Ciklobutil-metil)-8-dimetilamino-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-3-il]-metil]-benzamid;
CIS-1-(Ciklobutil-metil)-8-dimetilamino-3-[(4-hidroksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-1-(Ciklobutil-metil)-8-(etil-metil-amino)-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-1-[(1-metoksi-ciklobutil)-metil]-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-2-[[1-(Ciklobutil-metil)-8-dimetilamino-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-3-il]-metil]-benzonitril;
CIS-1-(Ciklobutil-metil)-8-dimetilamino-3-[(3-metilsulfonil-fenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-1-etil-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-3-[(4-metoksifenil)-metil]-8-fenil-1-propil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-3-Benzil-1-(ciklobutil-metil)-8-dimetilamino-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-3-[(4-metoksifenil)-metil]-8-fenil-1-(pyrimidm-4-il-metil)-1,3-diazaspiro[4.5]dekan-2-on;
CIS-3-[8-Dimetilamino-3-[(4-metoksifenil)-metil]-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-1-il]-2,2-dimetil-propionitril;
CIS-2-[[8-Dimetilamino-3-[(4-metoksifenil)-metil]-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-1-il]-metil]-metil ester benzojeve kiseline;
CIS-1-(Ciklobutil-metil)-8-dimetilamino-8-fenil-3-(piridin-2-il-metil)-1,3-diazaspiro[4.5]dekan-2-on;
CIS-1-(Ciklobutil-metil)-8-dimetilamino-8-fenil-3-(piridin-4-il-metil)-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-3-[(4-metoksifenil)-metil]-8-fenil-1-(tetrahidro-furan-3-il-metil)-1,3-diazaspiro[4.5]dekan-2-on;
CIS-1-(Ciklobutil-metil)-8-dimetilamino-8-fenil-3-(pirimidin-2-il-metil)-1,3-diazaspiro[4.5]dekan-2-on;
CIS-3-[[1-[(5-Cijano-2-metoksi-fenil)-metil]-8-dimetilamino-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-3-il]-metil]-4-metoksi-benzonitril;
CIS-8-Dimetilamino-1-(3-hidroksi-3-metil-butil)-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-1-(3-metoksi-3-metil-butil)-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-2-[[8-Dimetilamino-1-[(1-hidroksi-ciklobutil)-metil]-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-3-il]-metil]-benzamid;
CIS-3-[[8-Dimetilamino-1-[(1-hidroksi-ciklobutil)-metil]-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-3 -il]-metil] -benzamid;
CIS-8-Dimetilamino-3-[(4-metoksifenil)-metil]-1-(2-metilsulfonil-etil)-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-1-[(1-Hidroksi-ciklobutil)-metil]-3-[(4-metoksifenil)-metil]-8-metilamino-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-3-[(4-metoksifenil)-metil]-8-fenil-1-(tetrahidro-furan-2-il-metil)-1,3-diazaspiro[4.5]dekan-2-on;
CIS-3-Benzil-8-dimetilamino-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-3-Benzil-8-dimetilamino-1-etil-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-3-[(4-metoksifenil)-metil]-1-[2-(metilsulfinil)-etil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-1-[(2R)-2-hidroksi-propil]-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-1-[(2S)-2-hidroksi-propil]-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-3-[(4-metoksifenil)-metil]-8-fenil-1-(tetrahidro-furan-3-il-metil)-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-1-etil-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Amino-1-[(1-hidroksi-ciklobutil)-metil]-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-1-[(1-hidroksi-ciklobutil)-metil]-8-fenil-3-(2-fenil-etil)-1,3-diazaspiro-[4.5]dekan-2-on;
CIS-1-(Ciklobutil-metil)-8-dimetilamino-8-fenil-3-[(4-metoksifenil)-metil]-1,3-diazaspiro-[4.5]dekan-2-on;
CIS-3-[[8-Dimetilamino-1-[(1-hidroksi-ciklobutil)-metil]-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-3 -il]-metil] -4-metoksi-benzonitril;
CIS-8-Dimetilamino-1-etil-8-fenil-3-(piridin-3-il-metil)-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-1-[2-(1-metoksi-ciklobutil)-etil]-3-[(4-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-8-[3-(metoksimetiloksi)-fenil]-3-[(4-metoksifenil)-metil]-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-8-[4-(metoksimetiloksi)-fenil]-3-[(4-metoksifenil)-metil]-1,3-diazaspiro[4.5]dekan-2-on;
CIS-3-[8-Dimetilamino-3-[(4-metoksifenil)-metil]-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-1-il]-propionska kiselina;
CIS-3-[8-Dimetilamino-3-[(4-metoksifenil)-metil]-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-1-il]- tert-butil ester propionske kiseline;
CIS-2-[[1-(Ciklobutil-metil)-3-[(4-metoksifenil)-metil]-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-8-il]-metil-amino]-metil ester octene kiseline;
CIS-8-Dimetilamino-3-[(4-metoksifenil)-metil]-1-(3-metil-but-2-enil)-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-1-(Ciklobutil-metil)-8-dimetilamino-3-[(3-metilsulfanil-fenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-3-[(3-Bromofenil)-metil]-1-(ciklobutil-metil)-8-dimetilamino-8-fenil-1,3-diazaspiro[4.5]-dekan-2-on;
CIS-2-((8-(dimetilamino)-1-((1-hidroksiciklobutil)metil)-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-3-il)metil)benzonitril;
CIS-8-Dimetilamino-8-(3-metoksifenil)-3-[(4-metoksifenil)-metil]-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-8-(4-metoksifenil)-3-[(4-metoksifenil)-metil]-1,3-diazaspiro[4.5]dekan-2-on;
CIS-3-((8-(dimetilamino)-1-((1-hidroksiciklobutil)metil)-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-3-il)metil)benzonitril;
CIS-3-((8-(dimetilamino)-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-3-il)metil)-4-metoksibenzonitril;
CIS-8-Dimetilamino-8-fenil-3-(1H-[1,2,3]triazol-4-il-metil)-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-3-[[1-(2-hidroksi-etil)-1H-[1,2,3]triazol-4-il]-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-2-[4-[(8-Dimetilamino-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-3-il)-metil]-1H-[1,2,3]triazol-1-il]-acetamid;
CIS-8-Metilamino-8-fenil-3-(1H-[1,2,3]triazol-4-il-metil)-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-3-[(4-metoksifenil)-metil]-8-fenil-1-(p-tolilsulfonil)-1,3-diazaspiro[4.5]dekan-2-on;
CIS-2-[4-[(8-Metilamino-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-3-il)-metil]-1H-[1,2,3]triazol-1-il]-acetamid;
CIS-8-Dimetilamino-3-[(4-metoksifenil)-metil]-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-1- benzil ester karboksilne kiseline;
CIS-3-[[1-(2-Hidroksi-etil)-1H-[1,2,3]triazol-4-il]-metil]-8-metilamino-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-8-fenil-3-(2-piridin-2-il-etil)-1,3-diazaspiro[4.5]dekan-2,4-dion;
CIS-8-Dimetilamino-8-fenil-3-(2-piridin-2-il-etil)-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-1-[(1-hidroksi-ciklobutil)-metil]-3-[[1-(2-hidroksi-etil)-1H-[1,2,3]triazol-4-il]-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-3-[2-(1H-imidazol-1-il)-etil]-8-fenil-1,3-diazaspiro[4.5]dekan-2,4-dion;
CIS-2-[4-[[8-Dimetilamino-1-[(1-hidroksi-ciklobutil)-metil]-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-3-il]-metil]-1H-[1,2,3]triazol-1-il]-acetamid;
CIS-1-[(1-Hidroksi-ciklobutil)-metil]-3-[[1-(2-hidroksi-etil)-1H-[1,2,3]triazol-4-il]-metil]-8-metilamino-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-8-fenil-3-(2-piridin-3-il-etil)-1,3-diazaspiro[4.5]dekan-2,4-dion;
CIS-8-Dimetilamino-8-fenil-3-(2-piridin-4-il-etil)-1,3-diazaspiro[4.5]dekan-2,4-dion;
CIS-2-[4-[[1-(Ciklobutil-metil)-8-dimetilamino-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-3-il]-metil]-1H-[1,2,3]triazol-1-il]-acetamid;
CIS-1-(Ciklobutil-metil)-8-dimetilamino-3-[[1-(2-hidroksi-etil)-1H-[1,2,3]triazol-4-il]-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-2-[4-[[1-[(1-Hidroksi-ciklobutil)-metil]-8-metilamino-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-3-il]-metil]-1H-[1,2,3]triazol-1-il]-acetamid;
CIS-1-(Ciklobutil-metil)-3-[[1-(2-hidroksi-etil)-1H-[1,2,3]triazol-4-il]-metil]-8-metilamino-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-2-[4-[[1-(Ciklobutil-metil)-8-metilamino-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-3-il]-metil]-1H-[1,2,3]triazol-1-il]-acetamid;
CIS-8-Dimetilamino-8-fenil-3-(2-piridin-3-il-etil)-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-3-[2-(1H-imidazol-1-il)-etil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-8-fenil-3-(2-piridin-4-il-etil)-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-8-fenil-3-(2-pirimidin-2-il-etil)-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-8-fenil-3-(2-pirimidin-5-il-etil)-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-1-etil-3-[(4-metilsulfonil-fenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-3-(1-metil-1-fenil-etil)-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-8-fenil-3-(1-fenil-ciklopropil)-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-1,3-bis[(2-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-3-[(3-metilsulfonil-fenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-1-[(1-hidroksi-ciklobutil)-metil]-3-(1-metil-1-fenil-etil)-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-3-[(3-Ciklopropil-fenil)-metil]-8-dimetilamino-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-3-(1,3-Benzodioksol-4-il-metil)-8-dimetilamino-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-1-[(1-hidroksi-ciklobutil)-metil]-8-fenil-3-(1-fenil-ciklopropil)-1,3-diazaspiro[4.5]dekan-2-on;
CIS-4-[[8-Dimetilamino-3-[(2-metoksifenil)-metil]-2-okso-8-fenil-1,3-diazaspiro[4.5]dekan-1-il]-metil]-benzonitril;
CIS-8-Dimetilamino-3-[(2-metoksifenil)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-8-fenil-3-(piridin-4-il-metil)-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-8-fenil-3-(piridin-2-il-metil)-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-8-fenil-3-(piridin-3-il-metil)-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-3-[[2-(4-metil-piperazin-1-il)-piridin-4-il]-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-8-fenil-3-[(2-piperidin-1-il-piridin-4-il)-metil]-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-3-[(2-morpholin-4-il-piridin-4-il)-metil]-8-fenil-1,3-diazaspiro[4.5]dekan-2-on;
CIS-8-Dimetilamino-8-fenil-3-[(2-piperazin-1-il-piridin-4-il)-metil]-1,3-diazaspiro[4.5]dekan-2-on;
i njegove fiziološki prihvatljive soli.
14. Spoj prema bilo kojem od prethodnih patentnih zahtjeva za uporabu u liječenju bola.
15. Lijek koji sadrži spoj prema bilo kojem od patentnih zahtjeva 1-13.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16151013 | 2016-01-13 | ||
PCT/EP2017/025006 WO2017121648A1 (en) | 2016-01-13 | 2017-01-13 | 3-((hetero-)aryl)-alkyl-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives |
EP17701638.3A EP3402784B1 (en) | 2016-01-13 | 2017-01-13 | 3-((hetero-)aryl)-alkyl-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20200837T1 true HRP20200837T1 (hr) | 2020-08-07 |
Family
ID=55129634
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20200837TT HRP20200837T1 (hr) | 2016-01-13 | 2020-05-22 | Derivati 3-((hetero-)aril)-alkil-8-amino-2-okso-1,3-diaza-spiro-[4.5]-dekana |
Country Status (28)
Country | Link |
---|---|
US (6) | US20170197947A1 (hr) |
EP (1) | EP3402784B1 (hr) |
JP (1) | JP6893517B2 (hr) |
KR (1) | KR20180098369A (hr) |
CN (1) | CN108602777B (hr) |
AR (1) | AR107360A1 (hr) |
AU (1) | AU2017206909B2 (hr) |
BR (1) | BR112018014303B1 (hr) |
CA (1) | CA3011177A1 (hr) |
CL (1) | CL2018001912A1 (hr) |
CO (1) | CO2018008444A2 (hr) |
CY (1) | CY1122818T1 (hr) |
DK (1) | DK3402784T3 (hr) |
EA (1) | EA037481B1 (hr) |
EC (1) | ECSP18060848A (hr) |
ES (1) | ES2797904T3 (hr) |
HR (1) | HRP20200837T1 (hr) |
HU (1) | HUE049813T2 (hr) |
IL (1) | IL260491B (hr) |
LT (1) | LT3402784T (hr) |
MX (1) | MX2018008644A (hr) |
PE (1) | PE20181375A1 (hr) |
PL (1) | PL3402784T3 (hr) |
PT (1) | PT3402784T (hr) |
RS (1) | RS60315B1 (hr) |
SI (1) | SI3402784T1 (hr) |
TW (1) | TWI636048B (hr) |
WO (1) | WO2017121648A1 (hr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL3402781T3 (pl) | 2016-01-13 | 2020-09-21 | Grünenthal GmbH | Pochodne 3-((hetero-)arylo)-8-amino-2-okso-1,3-diazaspiro-[4.5]-dekanu |
DK3402785T3 (da) | 2016-01-13 | 2020-04-20 | Gruenenthal Gmbh | 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decan-derivater |
CN108602777B (zh) | 2016-01-13 | 2022-05-03 | 格吕伦塔尔有限公司 | 3-((杂-)芳基)-烷基-8-氨基-2-氧代-1,3-氮杂-螺-[4.5]-癸烷衍生物 |
SI3402783T1 (sl) | 2016-01-13 | 2020-10-30 | Gruenenthal Gmbh | Derivati 3-(karboksietil)-8-amino-2-okso-1,3-diaza-spiro-(4.5)-dekana |
HUE051642T2 (hu) | 2016-01-13 | 2021-03-01 | Gruenenthal Gmbh | 8-amino-2-oxo-1,3-diaza-spiro-[4,5]-dekán származékok |
CA3098428A1 (en) | 2018-04-18 | 2019-10-24 | Constellation Pharmaceuticals, Inc. | Modulators of methyl modifying enzymes, compositions and uses thereof |
CA3100977A1 (en) | 2018-05-21 | 2019-11-28 | Constellation Pharmaceuticals, Inc. | Modulators of methyl modifying enzymes, compositions and uses thereof |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2734265B1 (fr) | 1995-05-17 | 1997-06-13 | Adir | Nouveaux composes spiro heterocycliques, leur procede de preparation et les compositions pharmaceutiques les contenant |
MXPA03009602A (es) | 2001-04-18 | 2004-04-02 | Euro Celtique Sa | Analogos de nociceptina. |
DE10130020A1 (de) | 2001-06-25 | 2003-12-04 | Gruenenthal Gmbh | Substituierte 1-Oxa-2,8-diaza-spiro[4.5]dec-2-en-derivate |
DE10210195B4 (de) | 2002-03-07 | 2005-12-15 | Schwarz Pharma Ag | Verwendung von 1,3-Diazaspiro-[4,5]decan-2,4-dithion zur Behandlung von Schmerz |
EP1519939B9 (en) | 2002-07-05 | 2011-04-06 | Targacept, Inc. | N-aryl diazaspirocyclic compounds and methods of preparation and use thereof |
DE10252667A1 (de) * | 2002-11-11 | 2004-05-27 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
ZA200510329B (en) | 2003-05-23 | 2007-04-25 | Zealand Pharma As | Triaza-spiro compounds as nociceptin analogues and uses thereof |
JO2676B1 (en) | 2004-04-06 | 2012-06-17 | جانسين فارماسوتيكا ان. في | Derivatives of second-aza-spiro- (5,4) -dikan and their use as antihistamines |
EP2104665A2 (en) | 2006-10-19 | 2009-09-30 | F. Hoffmann-Roche AG | Imidazolone and imidazolidinone derivatives as 11b-hsd1 inhibitors for diabetes |
CN101679430B (zh) | 2007-04-09 | 2013-12-25 | 詹森药业有限公司 | 用于治疗焦虑和抑郁症的作为orl-1受体的配体的1,3,8-三取代-1,3,8-三氮杂-螺[4.5]癸-4-酮衍生物 |
NZ600207A (en) * | 2008-03-27 | 2013-09-27 | Gruenenthal Chemie | Substituted 4-aminocyclohexane derivatives |
US8268853B2 (en) | 2009-06-25 | 2012-09-18 | Abbott Laboratories | 3,9-diazaspiro[5,5]undecane amides and ureas and methods of use thereof |
TWI582092B (zh) | 2010-07-28 | 2017-05-11 | 歌林達股份有限公司 | 順式-四氫-螺旋(環己烷-1,1’-吡啶[3,4-b]吲哚)-4-胺-衍生物 |
US9884844B2 (en) * | 2012-12-31 | 2018-02-06 | Sunovion Pharmaceuticals, Inc. | Heterocyclic compounds and methods of use thereof |
EP3154971A4 (en) | 2014-06-13 | 2017-11-01 | Purdue Pharma L.P. | Heterocyclic morphinan derivatives and use thereof |
HUE051642T2 (hu) | 2016-01-13 | 2021-03-01 | Gruenenthal Gmbh | 8-amino-2-oxo-1,3-diaza-spiro-[4,5]-dekán származékok |
SI3402783T1 (sl) | 2016-01-13 | 2020-10-30 | Gruenenthal Gmbh | Derivati 3-(karboksietil)-8-amino-2-okso-1,3-diaza-spiro-(4.5)-dekana |
CN108602777B (zh) | 2016-01-13 | 2022-05-03 | 格吕伦塔尔有限公司 | 3-((杂-)芳基)-烷基-8-氨基-2-氧代-1,3-氮杂-螺-[4.5]-癸烷衍生物 |
PL3402781T3 (pl) | 2016-01-13 | 2020-09-21 | Grünenthal GmbH | Pochodne 3-((hetero-)arylo)-8-amino-2-okso-1,3-diazaspiro-[4.5]-dekanu |
TWI730032B (zh) | 2016-01-13 | 2021-06-11 | 美商必治妥美雅史谷比公司 | 作為rock抑制劑之螺庚烷水楊酸醯胺及相關化合物 |
HRP20220720T1 (hr) | 2016-01-13 | 2022-09-30 | Novo Nordisk A/S | Analozi egf(a) s masnim kiselinama kao supstituentima |
DK3402785T3 (da) | 2016-01-13 | 2020-04-20 | Gruenenthal Gmbh | 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decan-derivater |
-
2017
- 2017-01-13 CN CN201780006494.6A patent/CN108602777B/zh active Active
- 2017-01-13 EA EA201891609A patent/EA037481B1/ru unknown
- 2017-01-13 PT PT177016383T patent/PT3402784T/pt unknown
- 2017-01-13 JP JP2018536484A patent/JP6893517B2/ja active Active
- 2017-01-13 LT LTEP17701638.3T patent/LT3402784T/lt unknown
- 2017-01-13 HU HUE17701638A patent/HUE049813T2/hu unknown
- 2017-01-13 WO PCT/EP2017/025006 patent/WO2017121648A1/en active Application Filing
- 2017-01-13 AU AU2017206909A patent/AU2017206909B2/en active Active
- 2017-01-13 US US15/405,896 patent/US20170197947A1/en not_active Abandoned
- 2017-01-13 EP EP17701638.3A patent/EP3402784B1/en active Active
- 2017-01-13 SI SI201730268T patent/SI3402784T1/sl unknown
- 2017-01-13 PE PE2018001302A patent/PE20181375A1/es unknown
- 2017-01-13 RS RS20200585A patent/RS60315B1/sr unknown
- 2017-01-13 TW TW106101125A patent/TWI636048B/zh active
- 2017-01-13 BR BR112018014303-0A patent/BR112018014303B1/pt active IP Right Grant
- 2017-01-13 PL PL17701638T patent/PL3402784T3/pl unknown
- 2017-01-13 CA CA3011177A patent/CA3011177A1/en active Pending
- 2017-01-13 KR KR1020187021562A patent/KR20180098369A/ko active IP Right Grant
- 2017-01-13 DK DK17701638.3T patent/DK3402784T3/da active
- 2017-01-13 ES ES17701638T patent/ES2797904T3/es active Active
- 2017-01-13 MX MX2018008644A patent/MX2018008644A/es unknown
- 2017-01-13 AR ARP170100095A patent/AR107360A1/es unknown
-
2018
- 2018-05-21 US US15/984,919 patent/US20180327392A1/en not_active Abandoned
- 2018-07-09 IL IL260491A patent/IL260491B/en unknown
- 2018-07-13 CL CL2018001912A patent/CL2018001912A1/es unknown
- 2018-08-13 EC ECSENADI201860848A patent/ECSP18060848A/es unknown
- 2018-08-13 CO CONC2018/0008444A patent/CO2018008444A2/es unknown
-
2019
- 2019-02-01 US US16/265,080 patent/US10829480B2/en active Active
-
2020
- 2020-05-04 CY CY20201100402T patent/CY1122818T1/el unknown
- 2020-05-22 HR HRP20200837TT patent/HRP20200837T1/hr unknown
- 2020-08-31 US US17/007,258 patent/US20200399252A1/en not_active Abandoned
-
2021
- 2021-03-01 US US17/188,743 patent/US20210179592A1/en not_active Abandoned
-
2023
- 2023-01-30 US US18/103,180 patent/US20230174520A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20200837T1 (hr) | Derivati 3-((hetero-)aril)-alkil-8-amino-2-okso-1,3-diaza-spiro-[4.5]-dekana | |
JP2019501939A5 (hr) | ||
HRP20200782T1 (hr) | Derivati 3-((hetero-)aril)-8-amino-2-okso-1,3-diaza-spiro-[4.5]-dekana | |
CA2861556C (en) | Lactam derivatives useful as inhibitors of mutant idh1 | |
JP5966014B2 (ja) | 新規トリフルオロメチル−オキサジアゾール誘導体および疾患の処置におけるその使用 | |
HRP20170112T1 (hr) | Supstituirani spojevi piridin-2-karboksamida kao kinazni inhibitori signalne regulacije apoptoze | |
KR20140084146A (ko) | 신규 옥사진 유도체 및 질환의 치료에서의 그의 용도 | |
JP2019520416A5 (hr) | ||
AU2022203169B2 (en) | Sulfoxyalkyl organonitro and related compounds and pharmaceutical compositions for use in medicine | |
JP2012522007A5 (hr) | ||
HRP20160678T1 (hr) | Derivati 2-(1,2,3-triazol-2-il)benzamida i 3-(1,2,3-triazol-2-il)pikolinamida kao antagonisti receptora oreksina | |
JP2013510883A5 (hr) | ||
JP2022188052A (ja) | 痛風または高尿酸血症に関連する症状を処置または予防するための化合物、組成物、および方法 | |
JP6885629B2 (ja) | インドリノン化合物の使用 | |
HRP20220886T1 (hr) | Pripravci i postupci za proizvodnju pirimidina i spojeva piridina s btk inhibicijskom aktivnošću | |
WO2013027188A1 (en) | 2 -amino-4 - (pyridin- 2 -yl) - 5, 6 -dihydro-4h- 1, 3 -oxazine derivatives and their use as bace-1 and/or bace - 2 inhibitors | |
JP2019501937A5 (hr) | ||
JP2005526028A5 (hr) | ||
AU2019204181B2 (en) | Novel quinazolinone derivatives inhibiting pi3k and pharmaceutical composition containing same | |
JP2013510884A5 (hr) | ||
JP2023071905A (ja) | 癌を処置するためのezh2阻害剤 | |
JP2020503293A5 (hr) | ||
JP2013527847A5 (hr) | ||
HRP20171567T1 (hr) | Supstituirani 2-alkil-1-okso-n-fenil-3-heteroaril-1,2,3,4-tetrahidroizohinolin-4-karboksamidi za antimalarijske terapije | |
CA3065318A1 (en) | Methods for treatment of fibrotic diseases |